FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Giuseppe Saglio

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Treatment Outcome

Anatomy

Philadelphia Chromosome

Physiology

Genes & Molecular Sequences

Genes, abl

Co-author Network

Publications

TOP 3
Richard A Van Etten; Carlo Gambacorti-Passerini; John M Goldman; Rüdiger Hehlmann; Catriona Jamieson; Giovanni Martinelli; Michael Mauro; Danilo Perrotti; Jerald P Radich; Giuseppe Saglio; David T Scadden; Tomasz Skorski; Simona Soverini; Ayalew Tefferi; Tariq I Mughal
Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop.
Andreas Hochhaus; Albert Hoenekopp; Carmino De Souza; Gabriel Etienne; Xiaolin Fan; Matt E Kalaycio; Hagop M Kantarjian; Dong-Wook Kim; Mineo Kurokawa; Richard A Larson; Gianantonio Rosti; Giuseppe Saglio; Yaping Shou; Timothy P Hughes
Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Daniela Cilloni; Luciana De Luca; Alessandra Favole; Francesco Frassoni; Valentina Gaidano; Ilaria Iacobucci; Annalisa Morano; Pellegrino Musto; Pimjai Niparuck; Valentina Rosso; Enrico Bracco; Chiara Calabrese; Valentina Campia; Sonia Carturan; Elisabetta Signorino; Davide Torti; Giuseppe Saglio
Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Giuseppe Saglio (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard A Van Etten; Carlo Gambacorti-Passerini; John M Goldman; Rüdiger Hehlmann; Catriona Jamieson; Giovanni Martinelli; Michael Mauro; Danilo Perrotti; Jerald P Radich; Giuseppe Saglio; David T Scadden; Tomasz Skorski; Simona Soverini; Ayalew Tefferi; Tariq I Mughal
Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop.
Leukemia & lymphoma 2013;54(6):1151-8.
2013: Andreas Hochhaus; Albert Hoenekopp; Carmino De Souza; Gabriel Etienne; Xiaolin Fan; Matt E Kalaycio; Hagop M Kantarjian; Dong-Wook Kim; Mineo Kurokawa; Richard A Larson; Gianantonio Rosti; Giuseppe Saglio; Yaping Shou; Timothy P Hughes
Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Blood 2013;121(18):3703-8.
2013: Daniela Cilloni; Luciana De Luca; Alessandra Favole; Francesco Frassoni; Valentina Gaidano; Ilaria Iacobucci; Annalisa Morano; Pellegrino Musto; Pimjai Niparuck; Valentina Rosso; Enrico Bracco; Chiara Calabrese; Valentina Campia; Sonia Carturan; Elisabetta Signorino; Davide Torti; Giuseppe Saglio
Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia.
Leukemia research 2013;37(5):520-30.
2013: Sabrina Angelini; Michele Baccarani; Matt Barnett; Giorgio Cantelli-Forti; Daniela Cilloni; Patrizia Hrelia; Timothy P Hughes; Ilaria Iacobucci; Dong Wook Kim; Fabrizio Pane; Giovanni Perini; Jerald Radich; Gloria Ravegnini; Giuseppe Saglio; Simona Soverini; Mark Thornquist; Eleonora Turrini; Deborah L White; Richard Woodman; Giovanni Martinelli
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy.
Haematologica 2013;98(2):193-200.
2012: Susan Branford; Ariful Haque; Andreas Hochhaus; Timothy P Hughes; Hagop M Kantarjian; Dong-Wook Kim; Giovanni Martinelli; Jerald P Radich; Giuseppe Saglio; Yaping Shou; Simona Soverini; Richard C Woodman; Martin C Müller
Initial molecular response at 3 months may predict both response and event-free survival at 24 months in imatinib-resistant or -intolerant patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with nilotinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(35):4323-9.
2012: Juan Luis Steegmann; Francisco Cervantes; Philipp le Coutre; Kimmo Porkka; Giuseppe Saglio
Off-target effects of BCR-ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia.
Leukemia & lymphoma 2012;53(12):2351-61.
2012: Carmen Fava; Giovanna Rege-Cambrin; Giuseppe Saglio
Chronic myeloid leukemia: state of the art in 2012.
Current oncology reports 2012;14(5):379-86.
2012: Richard A Larson; B Moiraghi; Giuseppe Saglio; R Yu; D-W Kim; M Kurokawa; R E Blakesley; R E Clark; G Etienne; Ian W Flinn; N J Gallagher; A Hochhaus; T P Hughes; Hagop M Kantarjian
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up.
Leukemia 2012;26(10):2197-203.
2012: Rosa M Pellegrino; Jorge P Pinto; Graça Porto; Giuseppe Saglio; Gabriella Zecchina; José Barbot; Francesca Carnuccio; Emília Costa; Mónica Costa; Maria Coutinho; Domenico D'Ascola; Ana M Lopes; Antonietta Palmieri; Antonella Roetto
Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form.
British journal of haematology 2012;158(5):668-72.
2012: Elias Jabbour; Jerald Radich; Giuseppe Saglio; Hagop Kantarjian
Adherence to BCR-ABL inhibitors: issues for CML therapy.
Clinical lymphoma, myeloma & leukemia 2012;12(4):223-9.
2012: Ophelia Q P Yin; Philipp le Coutre; Giuseppe Saglio; Michele Baccarani; Ovidiu Chiparus; Neil Gallagher; Frank J Giles; Andreas Hochhaus; Timothy P Hughes; Hagop M Kantarjian; Richard A Larson
Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia.
Cancer chemotherapy and pharmacology 2012;70(2):345-50.
2012: Simona Luatti; Marco Mancini; Giovanni Martinelli; Giulia Marzocchi; Francesca Palandri; Giandomenico Palka; Fabrizio Pane; Giovanna Rege-Cambrin; Gianantonio Rosti; Giuseppe Saglio; Giorgina Specchia; Nicoletta Testoni; Alfonso Zaccaria; Lucia Zanatta; Elisabetta Abruzzese; Gaia Ameli; Michele Baccarani; Carmen Baldazzi; Paolo Bernasconi; Maria Adele Capucci; Fausto Castagnetti; Alessandro Gozzetti; Maria Grazia Grimoldi; Gabriele Gugliotta; Ilaria Iacobucci
Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis.
Blood 2012;120(4):761-7.
2012: Joëlle Guilhot; Michele Baccarani; Francisco Cervantes; Richard E Clark; François Guilhot; Andreas Hochhaus; Sergei Kulikov; Jiri Mayer; Andreas L Petzer; Gianantonio Rosti; Philippe Rousselot; Giuseppe Saglio; Susanne Saussele; Bengt Simonsson; Juan-Luis Steegmann; Andrey Zaritskey; Rüdiger Hehlmann
Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.
Blood 2012;119(25):5963-71.
2012: Deborah L White; Richard Woodman; Daniela Cilloni; Phuong Dang; Amity K Frede; Dong Wook Kim; Peter Lin; Paul Manley; Giovanni Martinelli; Lidia Mongay; Fabrizio Pane; Jerald Radich; Giuseppe Saglio; Verity A Saunders; Cassandra Slader; Simona Soverini; Timothy P Hughes
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib.
Haematologica 2012;97(6):907-14.
2012: Claudia Casnici; Katia Crotta; Donatella Lattuada; Giuseppe Saglio; Gisella Volpe; Ornella Marelli
Immunologic evaluation of peptides derived from BCR/ABL-out-of-frame fusion protein in HLA A2.1 transgenic mice.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2012;35(4):321-8.
2012: Richard A Larson; Hirohisa Nakamae; Giuseppe Saglio; Ophelia Q P Yin; Richard E Clark; Eren Demirhan; Neil J Gallagher; Andreas Hochhaus; Timothy P Hughes; Hagop M Kantarjian; Philipp D le Coutre
Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase.
European journal of clinical pharmacology 2012;68(5):723-33.
2012: Elias Jabbour; Timothy P Hughes; Giuseppe Saglio; Hagop Kantarjian
Suboptimal responses in chronic myeloid leukemia: implications and management strategies.
Cancer 2012;118(5):1181-91.
2012: Daniela Cilloni; Giuseppe Saglio
Molecular pathways: BCR-ABL.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(4):930-7.
2012: Antonio D'Avolio; Silvia De Francia; Francesco Di Carlo; Alessandra Ariaudo; Lorena Baietto; Jessica Cusato; Carmen Fava; Giuseppe Saglio; Marco Simiele; Giovanni Di Perri
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC).
Journal of pharmaceutical and biomedical analysis 2012;59():109-16.
2011: Franck Emmanuel Nicolini; Eduardo Olavarria; Senaka Peter; Giovanna Rege-Cambrin; Giuseppe Saglio; Simona Soverini; Wei Zhou; Jane F Apperley; Grzegorz W Basak; Charles Chuah; Inge H Dufva; Gabriel Etienne; Sandrine Hayette; Andreas Hochhaus; Hélène Labussière; Giovanni Martinelli; Michael J Mauro; Mauricette Michallet; Stéphane Morisset; Martin C Müller; Jorge Cortes
Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias.
Blood 2011;118(20):5697-700.
2011: Elisa Pirro; Silvia Racca; Giuseppe Saglio; Stefano Ulisciani; Giovanna Rege Cambrin; Silvia De Francia; Francesca De Martino; Carmen Fava; Francesco Di Carlo
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients.
Journal of chromatographic science 2011;49(10):753-7.
2011: Patrizia Falco; Dario Ferrero; R Freilone; Gianluca Gaidano; Massimo Geuna; Daniela Gioia; Mauro Girotto; Alessandro Levis; Carlo Marinone; Filippo Marmont; Patrizia Notari; Paola Omedè; Marisa Pautasso; Berardino Pollio; Giuseppina Prato; Giuseppe Saglio; Flavia Salvi; Alessandra Stacchini; Giuliana Strola; Margherita Bonferroni; Gianni Cametti; Maria M Ciriello
Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
European journal of haematology 2011;87(5):409-18.
2011: Nicola Esposito; Timothy P Hughes; Thea Kalebic; Luigia Luciano; Giovanni Martinelli; Rosanna Martinelli; Junia V Melo; Anna Lucia Peluso; Marco Picardi; Concetta Quintarelli; Jerald P Radich; Margherita Ruoppolo; Domenico Russo; Giuseppe Saglio; Agostino Rodeo Sica; Deborah White; Susan Branford; Tonia Buonomo; Irene Colavita; Luigi Del Vecchio; Fabrizio Pane
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia.
Blood 2011;118(13):3634-44.
2011: Hagop M Kantarjian; Richard A Larson; Hirohisa Nakamae; Gianantonio Rosti; Giuseppe Saglio; Leif Stenke; Carmino De Souza; Rick E Blakesley; Ian W Flinn; Neil J Gallagher; Yeow Tee Goh; Andreas Hochhaus; Albert Hoenekopp; Timothy P Hughes
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.
The lancet oncology 2011;12(9):841-51.
2011: Simona Soverini; Michele Baccarani; Nicholas C P Cross; Thomas Ernst; Franz Gruber; Andreas Hochhaus; Thoralf Lange; Martin C Müller; Franck E Nicolini; Fabrizio Pane; Kimmo Porkka; Gianantonio Rosti; Giuseppe Saglio; Giovanni Martinelli
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.
Blood 2011;118(5):1208-15.
2011: Giulia Marzocchi; Anna Montaldi; Francesca Palandri; Fabrizio Pane; Gianantonio Rosti; Giuseppe Saglio; Alessandra Santoro; Mario Sessarego; Giorgina Specchia; Monica Stacchini; Nicoletta Testoni; Laura Valori; Marilina Amabile; Michele Baccarani; Carmen Baldazzi; Laura Bonaldi; Fausto Castagnetti; Anna Maria Cianciulli; Giancarlo Discepoli; Francesca Giacobbi; Giovanni Giudici; Ursula Giussani; Gabriele Gugliotta; Simona Luatti; Giovanni Martinelli
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.
Blood 2011;117(25):6793-800.
2011: Claudia Casnici; Katia Crotta; Debora Lattuada; Renato Longhi; Cristina Panuzzo; Giuseppe Saglio; Gisella Volpe; Carla Alba Cabras; Ornella Marelli
Characterization of a monoclonal antibody specific for novel Bcr/Abl out-of-frame fusion proteins.
Hybridoma (2005) 2011;30(3):261-9.
2011: Elias Jabbour; Susan Branford; Giuseppe Saglio; Dan Jones; Jorge E Cortes; Hagop M Kantarjian
Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Cancer 2011;117(9):1800-11.
2011: Hyun-Gyung Goh; Min Lin; Takashi Fukushima; Giuseppe Saglio; Dongho Kim; Soo-Young Choi; Soo-Hyun Kim; Jeong Lee; Young-Seok Lee; Sang-Mi Oh; Dong-Wook Kim
Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay.
Leukemia & lymphoma 2011;52(5):896-904.
2011: Tommasina Guglielmelli; Sara Bringhen; S Rrodhe; Francesca Gay; Federica Cavallo; Alfredo Berruti; Vittorio Montefusco; E Piro; G Benevolo; Maria Teresa Petrucci; Tommaso Caravita; M Offidani; Paolo Corradini; Mario Boccadoro; Giuseppe Saglio; Antonio Palumbo
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients.
European journal of cancer (Oxford, England : 1990) 2011;47(6):814-8.
2011: Hagop M Kantarjian; Michele Baccarani; Elias Jabbour; Giuseppe Saglio; Jorge E Cortes
Second-generation tyrosine kinase inhibitors: the future of frontline CML therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(7):1674-83.
2011: Giuliana Alimena; Massimo Breccia; Pellegrino Musto; Daniela Cilloni; Fiorella D'Auria; Roberto Latagliata; Grazia Sanpaolo; Enrico Gottardi; Giuseppe Saglio; Franco Mandelli
Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes.
Leukemia research 2011;35(4):504-7.
2011: Hagop M Kantarjian; Francis J Giles; Kapil N Bhalla; Javier Pinilla-Ibarz; Richard A Larson; Norbert Gattermann; Oliver G Ottmann; Andreas Hochhaus; Jerald P Radich; Giuseppe Saglio; Timothy P Hughes; Giovanni Martinelli; Dong-Wook Kim; Yaping Shou; Neil J Gallagher; Rick Blakesley; Michele Baccarani; Jorge Cortes; Philipp D le Coutre
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results.
Blood 2011;117(4):1141-5.
2011: Tommasina Guglielmelli; Maria Teresa Petrucci; Giuseppe Saglio; Antonio Palumbo
Thalidomide after lenalidomide: a possible treatment regimen in relapse refractory multiple myeloma patients.
British journal of haematology 2011;152(1):108-10.
2010: Giuseppe Saglio; Hagop Kantarjian; Tessa Holyoake; Aarati Ranganathan; Jorge E Cortés
Proceedings of the Third Global Workshop on Chronic Myeloid Leukemia.
Clinical lymphoma, myeloma & leukemia 2010;10(6):443-51.
2010: Francis J Giles; Gianantonio Rosti; Photis Beris; Richard E Clark; Philipp le Coutre; Francois-Xavier Mahon; Juan-Luis Steegmann; Peter Valent; Giuseppe Saglio
Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study.
Expert review of hematology 2010;3(6):665-73.
2010: Carmen Fava; Giuseppe Saglio
Can we and should we improve on frontline imatinib therapy for chronic myeloid leukemia?
Seminars in hematology 2010;47(4):319-26.
2010: Daniela Cilloni; Francesco Frassoni; Giuseppe Saglio
Emerging targets for hematological malignancies.
Current opinion in drug discovery & development 2010;13(5):548-58.
2010: Giuseppe Saglio; Andreas Hochhaus; Yeow Tee Goh; Tamas Masszi; Ricardo Pasquini; Frederic Maloisel; Philipp Erben; Jorge Cortes; Ronald Paquette; M Brigid Bradley-Garelik; Chao Zhu; Herve Dombret
Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily.
Cancer 2010;116(16):3852-61.
2010: Emanuela Messa; Sonia Carturan; Chiara Maffè; Marisa Pautasso; Enrico Bracco; Antonella Roetto; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Valentina Rosso; Chiara Zanone; Antonia Rotolo; Elisabetta Greco; Rosa M Pellegrino; Daniele Alberti; Giuseppe Saglio; Daniela Cilloni
Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.
Haematologica 2010;95(8):1308-16.
2010: Francesca Palandri; Fausto Castagnetti; Ilaria Iacobucci; Giovanni Martinelli; Marilina Amabile; Gabriele Gugliotta; Angela Poerio; Nicoletta Testoni; Massimo Breccia; Monica Bocchia; Monica Crugnola; Giovanna Rege-Cambrin; Bruno Martino; Ivana Pierri; Franca Radaelli; Giorgina Specchia; Fabrizio Pane; Giuseppe Saglio; Gianantonio Rosti; Michele Baccarani
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase.
Haematologica 2010;95(8):1415-9.
2010: Giuseppe Saglio; Dong-Wook Kim; Surapol Issaragrisil; Philipp le Coutre; Gabriel Etienne; Clarisse Lobo; Ricardo Pasquini; Richard E Clark; Andreas Hochhaus; Timothy P Hughes; Neil Gallagher; Albert Hoenekopp; Mei Dong; Ariful Haque; Richard A Larson; Hagop M Kantarjian
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
The New England journal of medicine 2010;362(24):2251-9.
2010: Giuseppe Saglio; Michele Baccarani
First-line therapy for chronic myeloid leukemia: new horizons and an update.
Clinical lymphoma, myeloma & leukemia 2010;10(3):169-76.
2010: Fausto Castagnetti; Nicoletta Testoni; Simona Luatti; Giulia Marzocchi; Marco Mancini; Simonetta Kerim; Emilia Giugliano; Francesco Albano; Antonio Cuneo; Elisabetta Abruzzese; Bruno Martino; Francesca Palandri; Marilina Amabile; Ilaria Iacobucci; Giuliana Alimena; Fabrizio Pane; Giovanni Martinelli; Giuseppe Saglio; Michele Baccarani; Gianantonio Rosti
Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(16):2748-54.
2010: Daniela Cilloni; Emanuela Messa; Antonia Rotolo; Giuseppe Saglio
Emerging drugs for chronic myeloid leukemia.
Expert opinion on emerging drugs 2010;15(2):175-84.
2010: Giuseppe Saglio
The best frontline therapy for CML: imatinib?
Clinical advances in hematology & oncology : H&O 2010;8(4):240-2.
2010: Roberta La Starza; Caterina Matteucci; Paolo Gorello; Lucia Brandimarte; Valentina Pierini; Barbara Crescenzi; Valeria Nofrini; Roberto Rosati; Enrico Gottardi; Giuseppe Saglio; Antonella Santucci; Laura Berchicci; Francesco Arcioni; Brunangelo Falini; Massimo Fabrizio Martelli; Constantina Sambani; Anna Aventin; Cristina Mecucci
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia.
PloS one 2010;5(9):e12855.
2010: Emanuela Messa; Daniela Cilloni; Giuseppe Saglio
Iron chelation therapy in myelodysplastic syndromes.
Advances in hematology 2010;2010():756289.
2010: Ilaria Iacobucci; A Lonetti; F Messa; A Ferrari; Daniela Cilloni; Simona Soverini; F Paoloni; F Arruga; Emanuela Ottaviani; S Chiaretti; M Messina; Marco Vignetti; Cristina Papayannidis; A Vitale; Fabrizio Pane; Pier Paolo Piccaluga; S Paolini; G Berton; A Baruzzi; Giuseppe Saglio; Michele Baccarani; R Foà; giovanni martinelli
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.
Leukemia 2010;24(1):66-73.
2009: Michele Baccarani; Jorge Cortes; Fabrizio Pane; Dietger Niederwieser; Giuseppe Saglio; Jane Apperley; Francisco Cervantes; Michael W N Deininger; Alois Gratwohl; François Guilhot; Andreas Hochhaus; Mary Horowitz; Timothy Hughes; Andrew Lamb; Richard Larson; Jerald Radich; Bengt Simonsson; Richard T Silver; John Goldman; Rudiger Hehlmann
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):6041-51.
2009: Gianantonio Rosti; Francesca Palandri; Fausto Castagnetti; Massimo Breccia; Luciano Levato; Gabriele Gugliotta; Adele Capucci; Michele Cedrone; Carmen Fava; Tamara Intermesoli; Giovanna Rege Cambrin; Fabio Stagno; Mario Tiribelli; Marilina Amabile; Simona Luatti; Angela Poerio; Simona Soverini; Nicoletta Testoni; Giovanni Martinelli; Giuliana Alimena; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani
Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia.
Blood 2009;114(24):4933-8.
2009: Francesca Pellicano; Daniela Cilloni; G Vignir Helgason; Francesca Messa; Cristina Panuzzo; Francesca Arruga; Enrico Bracco; Elaine K Allan; Brian J P Huntly; Tessa L Holyoake; Giuseppe Saglio
FOXO transcription factor activity is partially retained in quiescent CML stem cells and induced by tyrosine kinase inhibitors in CML progenitor cells.
Blood 2009;():.
2009: Giovanni Martinelli; Ilaria Iacobucci; Clelia Tiziana Storlazzi; Marco Vignetti; Francesca Paoloni; Daniela Cilloni; Simona Soverini; Antonella Vitale; Sabina Chiaretti; Giuseppe Cimino; Cristina Papayannidis; Stefania Paolini; Loredana Elia; Paola Fazi; Giovanna Meloni; Sergio Amadori; Giuseppe Saglio; Fabrizio Pane; Michele Baccarani; Robin Foà
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5202-7.
2009: Daniela Cilloni; Aline Renneville; fabienne hermitte; Robert K Hills; Sarah Daly; Jelena V Jovanovic; Enrico Gottardi; Milena Fava; Susanne Schnittger; Tamara Weiss; Barbara Izzo; Josep Nomdedeu; Adrian van der Heijden; Bert A van der Reijden; Joop H Jansen; Vincent H J van der Velden; Hans Ommen; Claude Preudhomme; Giuseppe Saglio; David Grimwade
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5195-201.
2009: Giuseppe Saglio; Carmen Fava
Inhibition of stromal cell-derived factor-1/CXCR4 axis for the cure of BCR-ABL positive chronic myeloid leukemia.
Leukemia & lymphoma 2009;50(10):1564-5.
2009: Paolo Nicoli; Ubaldo Familiari; Marco Bosa; Tiziano Allice; Francesca Mete; Alessandro Morotti; Daniela Cilloni; Giuseppe Saglio; Angelo Guerrasio
HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
International journal of hematology 2009;90(3):392-6.
2009: Ilaria Iacobucci; Clelia Tiziana Storlazzi; Daniela Cilloni; Annalisa Lonetti; Emanuela Ottaviani; Simona Soverini; Annalisa Astolfi; Sabina Chiaretti; Antonella Vitale; Francesca Messa; Luciana Impera; Carmen Baldazzi; Pietro D'Addabbo; Cristina Papayannidis; Angelo Lonoce; Sabrina Colarossi; Marco Vignetti; Pier Paolo Piccaluga; Stefania Paolini; Domenico Russo; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; Robin Foà; Giovanni Martinelli
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
Blood 2009;114(10):2159-67.
2009: Daniela Cilloni; Giuseppe Saglio
CML: a model for targeted therapy.
Best practice & research. Clinical haematology 2009;22(3):285-94.
2009: Timothy Hughes; Giuseppe Saglio; Susan Branford; Simona Soverini; Dong-Wook Kim; Martin C Müller; Giovanni Martinelli; Jorge Cortes; Lan Beppu; Enrico Gottardi; Dongho Kim; Philipp Erben; Yaping Shou; Ariful Haque; Neil Gallagher; Jerald Radich; Andreas Hochhaus
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4204-10.
2009: Silvia De Francia; Antonio D'Avolio; Francesca De Martino; Elisa Pirro; Lorena Baietto; Marco Siccardi; Marco Simiele; Silvia Racca; Giuseppe Saglio; Francesco Di Carlo; Giovanni Di Perri
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(18-19):1721-6.
2009: Michele Baccarani; Gianantonio Rosti; Fausto Castagnetti; Ibrahim Haznedaroglu; Kimmo Porkka; Elisabetta Abruzzese; Giuliana Alimena; Hans Ehrencrona; Henrik Hjorth-Hansen; Veli Kairisto; Luciano Levato; giovanni martinelli; Arnon Nagler; Johan Lanng Nielsen; Ugur Ozbek; Francesca Palandri; Fausto Palmieri; Fabrizio Pane; Giovanna Rege-Cambrin; Domenico Russo; Giorgina Specchia; Nicoletta Testoni; Ole Weiss-Bjerrum; Giuseppe Saglio; Bengt Simonsson
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
Blood 2009;113(19):4497-504.
2009: Massimo Breccia; Daniela Cilloni; Laura Cannella; Caterina Stefanizzi; Agostino Tafuri; Angelo Fama; Michelina Santopietro; Giuseppe Saglio; Giuliana Alimena
Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose.
Cancer chemotherapy and pharmacology 2009;63(6):1161-3.
2009: Fausto Castagnetti; Francesca Palandri; Marilina Amabile; Nicoletta Testoni; Simona Luatti; Simona Soverini; Ilaria Iacobucci; Massimo Breccia; Giovanna Rege-Cambrin; Fabio Stagno; Giorgina Specchia; Piero Galieni; Franco Iuliano; Fabrizio Pane; Giuseppe Saglio; Giuliana Alimena; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party.
Blood 2009;113(15):3428-34.
2009: Claudia Casnici; Gisella Volpe; Debora Lattuada; K Crotta; Mirela Kuka; C Panuzzo; C Mastrotto; Giancarlo Tonon; V M Fazio; Giuseppe Saglio; Ornella Marelli
Out of frame peptides from BCR/ABL alternative splicing are immunogenic in HLA A2.1 transgenic mice.
Cancer letters 2009;276(1):61-7.
2009: Francesca Palandri; Ilaria Iacobucci; Simona Soverini; Fausto Castagnetti; Angela Poerio; Nicoletta Testoni; Giuliana Alimena; Massimo Breccia; Giovanna Rege-Cambrin; Mario Tiribelli; Riccardo Varaldo; Elisabetta Abruzzese; Bruno Martino; Luigiana Luciano; Fabrizio Pane; Giuseppe Saglio; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1059-63.
2009: Francesca Palandri; Fausto Castagnetti; Giuliana Alimena; Nicoletta Testoni; Massimo Breccia; Simona Luatti; Giovanna Rege-Cambrin; Fabio Stagno; Giorgina Specchia; Bruno Martino; Luciano Levato; Serena Merante; Anna Maria Liberati; Fabrizio Pane; Giuseppe Saglio; Daniele Alberti; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up.
Haematologica 2009;94(2):205-12.
2009: Christoph Walz; J Score; J Mix; D Cilloni; C Roche-Lestienne; R-F Yeh; J L Wiemels; E Ottaviani; Philipp Erben; Andreas Hochhaus; M Baccarani; D Grimwade; Claude Preudhomme; J Apperley; giovanni martinelli; Giuseppe Saglio; Nicholas C P Cross; Andreas Reiter
The molecular anatomy of the FIP1L1-PDGFRA fusion gene.
Leukemia 2009;23(2):271-8.
2009: Paolo Nicoli; Marco Bosa; Antonia Rotolo; Daniela Cilloni; Giuseppe Saglio
Herpetic leg paralysis and abdominal ileus in a patient with idiopathic myelofibrosis.
Internal and emergency medicine 2009;4(1):65-6.
2009: Tommasina Guglielmelli; Roberta Merlini; Emilia Giugliano; Giuseppe Saglio
Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia.
Journal of oncology 2009;2009():867380.
2009: Emanuela Messa; R M Pellegrino; A Palmieri; Sonia Carturan; Daniela Cilloni; Giuseppe Saglio; Antonella Roetto
Identification of a novel mutation in the L ferritin iron-responsive element causing hereditary hyperferritinemia-cataract syndrome.
Acta haematologica 2009;122(4):223-5.
2009: Francesca Palandri; Nicoletta Testoni; Simona Luatti; Giulia Marzocchi; Carmen Baldazzi; Monica Stacchini; Fausto Castagnetti; Massimo Breccia; Giorgina Specchia; Fabrizio Pane; Giuseppe Saglio; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results.
Leukemia & lymphoma 2009;50(1):114-8.
2008: Francesca Palandri; Fausto Castagnetti; Nicoletta Testoni; Simona Luatti; Giulia Marzocchi; Simona Bassi; Massimo Breccia; Giuliana Alimena; Ester Pungolino; Giovanna Rege-Cambrin; Riccardo Varaldo; Maurizio Miglino; Giorgina Specchia; Elisa Zuffa; Felicetto Ferrara; Monica Bocchia; Giuseppe Saglio; Fabrizio Pane; Daniele Alberti; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
Haematologica 2008;93(12):1792-6.
2008: Ilaria Iacobucci; Annalisa Lonetti; Daniela Cilloni; Francesca Messa; Anna Ferrari; Roberta Zuntini; Simona Ferrari; Emanuela Ottaviani; Francesca Arruga; Stefania Paolini; Cristina Papayannidis; Pier Paolo Piccaluga; Simona Soverini; Giuseppe Saglio; Fabrizio Pane; Anna Baruzzi; Marco Vignetti; Giorgio Berton; Antonella Vitale; Sabina Chiaretti; Markus Müschen; Robin Foà; Michele Baccarani; giovanni martinelli
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
Haematologica 2008;93(12):1814-21.
2008: Ilaria Iacobucci; Annalisa Lonetti; Francesca Messa; Daniela Cilloni; Francesca Arruga; Emanuela Ottaviani; Stefania Paolini; Cristina Papayannidis; Pier Paolo Piccaluga; Panagiota Giannoulia; Simona Soverini; Marilina Amabile; Angela Poerio; Giuseppe Saglio; Fabrizio Pane; Giorgio Berton; Anna Baruzzi; Antonella Vitale; Sabina Chiaretti; Giovanni Perini; Robin Foà; Michele Baccarani; giovanni martinelli
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
Blood 2008;112(9):3847-55.
2008: Susan Branford; Linda Fletcher; Nicholas C P Cross; Martin C Müller; Andreas Hochhaus; Dong-Wook Kim; Jerald P Radich; Giuseppe Saglio; Fabrizio Pane; Suzanne Kamel-Reid; Y Lynn Wang; Richard D Press; Kevin Lynch; Zbigniew Rudzki; John M Goldman; Timothy Hughes
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.
Blood 2008;112(8):3330-8.
2008: Francesco Lo Coco; Antonio Cuneo; Fabrizio Pane; Daniela Cilloni; Daniela Diverio; Marco Mancini; Nicoletta Testoni; Antonella Bardi; Barbara Izzo; Niccolò Bolli; Roberta La Starza; Paola Fazi; Simona Iacobelli; Alfonso Piciocchi; Marco Vignetti; Sergio Amadori; Franco Mandelli; Pier Giuseppe Pelicci; Cristina Mecucci; Brunangelo Falini; Giuseppe Saglio
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia.
Haematologica 2008;93(7):1017-24.
2008: Keisuke Ito; Rosa Bernardi; Alessandro Morotti; Sahoko Matsuoka; Giuseppe Saglio; Yasuo Ikeda; Jacalyn Rosenblatt; David E Avigan; Julie T Feldstein; Pier Paolo Pandolfi
PML targeting eradicates quiescent leukaemia-initiating cells.
Nature 2008;453(7198):1072-8.
2008: Marco Capobianco; Simona Malucchi; Stefano Ulisciani; Carmen Fava; Giovanna Rege Cambrin; Luigina Avonto; Giuseppe Saglio; Antonio Bertolotto
Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2008;29(3):185-7.
2008: Daniela Cilloni; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Enrico Gottardi; Milena Fava; Sonia Carturan; Renata Catalano; Enrico Bracco; Emanuela Messa; Paolo Nicoli; Daniela Diverio; Miguel A Sanz; giovanni martinelli; Francesco Lo Coco; Giuseppe Saglio
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy.
Haematologica 2008;93(6):921-4.
2008: Daniela Cilloni; Francesca Messa; Valentina Rosso; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Renata Catalano; Marisa Pautasso; C Panuzzo; P Nicoli; Emanuela Messa; Alessandro Morotti; I Iacobucci; giovanni martinelli; Enrico Bracco; Giuseppe Saglio
Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
Leukemia 2008;22(6):1234-40.
2008: Francesca Palandri; Ilaria Iacobucci; Fausto Castagnetti; Nicoletta Testoni; Angela Poerio; Marilina Amabile; Massimo Breccia; Tamara Intermesoli; Francesco Iuliano; Giovanna Rege-Cambrin; Mario Tiribelli; Maurizio Miglino; Fabrizio Pane; Giuseppe Saglio; giovanni martinelli; Gianantonio Rosti; Michele Baccarani
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome.
Haematologica 2008;93(5):770-4.
2008: Giuseppe Saglio; Stefano Ulisciani; Milena Fava; Enrico Gottardi; Daniela Cilloni
Molecular monitoring in patients with chronic myelogenous leukemia.
Current hematologic malignancy reports 2008;3(2):65-71.
2008: Giuseppe Saglio; Stefano Ulisciani; Marco Bosa; Daniela Cilloni; Giovanna Rege-Cambrin
New therapeutic approaches and prognostic factors in chronic myeloid leukemia.
Leukemia & lymphoma 2008;49(4):625-8.
2008: Brunangelo Falini; Cristina Mecucci; Giuseppe Saglio; Francesco Lo Coco; Daniela Diverio; Patrick Brown; Fabrizio Pane; Marco Mancini; Maria Paola Martelli; Stefano Pileri; Torsten Haferlach; Claudia Haferlach; Susanne Schnittger
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
Haematologica 2008;93(3):439-42.
2008: Philipp le Coutre; Oliver G Ottmann; Francis Giles; Dong-Wook Kim; Jorge Cortes; Norbert Gattermann; Jane F Apperley; Richard A Larson; Elisabetta Abruzzese; Stephen G O'Brien; Kazimierz Kuliczkowski; Andreas Hochhaus; Francois-Xavier Mahon; Giuseppe Saglio; marco gobbi; Yok-Lam Kwong; Michele Baccarani; Timothy Hughes; giovanni martinelli; Jerald P Radich; Ming Zheng; Yaping Shou; Andrew Lamb
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.
Blood 2008;111(4):1834-9.
2008: Michele Baccarani; Fabrizio Pane; Giuseppe Saglio
Monitoring treatment of chronic myeloid leukemia.
Haematologica 2008;93(2):161-9.
2008: John Porter; Renzo Galanello; Giuseppe Saglio; Ellis J Neufeld; Elliott Vichinsky; Maria Domenica Cappellini; Nancy F Olivieri; Antonio Piga; Melody J Cunningham; Denis Soulières; Norbert Gattermann; Gilbert Tchernia; Johan Maertens; Patricia J Giardina; Janet Kwiatkowski; Giovanni Quarta; Michael Jeng; Gian Luca Forni; Michael Stadler; Holger Cario; Louisette Debusscher; Matteo Della Porta; Mario Cazzola; Peter Greenberg; Giuliana Alimena; Bertrand Rabault; Insa Gathmann; John Malcolm Ford; Daniele Alberti; Christian Rose
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.
European journal of haematology 2008;80(2):168-76.
2008: Emanuela Messa; Daniela Cilloni; Francesca Messa; Francesca Arruga; A Roetto; Giuseppe Saglio
Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis.
Acta haematologica 2008;120(2):70-4.
2008: Paolo Nicoli; Ilaria Defilippi; Sonia Carturan; Antonella Roetto; Francesca Messa; Francesca Arruga; Emanuela Messa; Antonia Rotolo; Ilaria Iacobucci; Enrico Bracco; Giuseppe Saglio; Daniela Cilloni
Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignancies.
Acta haematologica 2008;120(1):47-50.
2008: Francesca Palandri; Ilaria Iacobucci; giovanni martinelli; Marilina Amabile; Angela Poerio; Nicoletta Testoni; Simona Soverini; Fausto Castagnetti; Antonio de Vivo; Massimo Breccia; Giorgina Specchia; Elisabetta Abruzzese; Bruno Martino; Daniela Cilloni; Giuseppe Saglio; Fabrizio Pane; Anna Marina Liberati; Gianantonio Rosti; Michele Baccarani
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):106-11.
2008: Martin C Müller; Philipp Erben; Giuseppe Saglio; Enrico Gottardi; C G Nyvold; T Schenk; T Ernst; S Lauber; J Kruth; Rüdiger Hehlmann; Andreas Hochhaus
Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories.
Leukemia 2008;22(1):96-102.
2007: Pier Paolo Piccaluga; Michele Malagola; Michela Rondoni; Mario Arpinati; Stefania Paolini; Anna Candoni; Renato Fanin; Emanuela Messa; Maria Teresa Pirrotta; Francesco Lauria; Giuseppe Visani; Daniele Alberti; Francesca Rancati; Vincenza Vinaccia; Domenico Russo; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study.
Haematologica 2007;92(12):1721-2.
2007: Michele Baccarani; Daniela Cilloni; Michela Rondoni; Emanuela Ottaviani; Francesca Messa; Serena Merante; Mario Tiribelli; Francesco Buccisano; Nicoletta Testoni; Enrico Gottardi; Antonio de Vivo; Emilia Giugliano; Ilaria Iacobucci; Stefania Paolini; Simona Soverini; Gianantonio Rosti; Francesca Rancati; Cinzia Astolfi; Fabrizio Pane; Giuseppe Saglio; giovanni martinelli
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.
Haematologica 2007;92(9):1173-9.
2007: Daniela Cilloni; giovanni martinelli; Francesca Messa; Michele Baccarani; Giuseppe Saglio
Nuclear factor kB as a target for new drug development in myeloid malignancies.
Haematologica 2007;92(9):1224-9.
2007: Daniela Cilloni; Francesca Messa; giovanni martinelli; Enrico Gottardi; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Emanuela Messa; Milena Fava; Emilia Giugliano; Valentina Rosso; Renata Catalano; Serena Merante; P Nicoli; Michela Rondoni; Emanuela Ottaviani; Simona Soverini; Mario Tiribelli; Fabrizio Pane; Michele Baccarani; Giuseppe Saglio
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.
Leukemia 2007;21(7):1442-50.
2007: J Saldanha; Monique Silvy; N Beaufils; R Arlinghaus; G Barbany; Susan Branford; Jean-Michel Cayuela; Giovanni Cazzaniga; M Gonzalez; David Grimwade; V Kairisto; K Miyamura; M Lawler; Thomas Lion; Elizabeth Macintyre; F-X Mahon; Martin C Muller; M Ostergaard; Heike Pfeifer; Giuseppe Saglio; Charles L Sawyers; Orietta Spinelli; V H J van der Velden; J Q Wang; K Zoi; V Patel; P Phillips; P Matejtschuk; Jean Gabert
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements.
Leukemia 2007;21(7):1481-7.
2007: Emanuela Messa; Daniela Cilloni; Giuseppe Saglio
A young man with persistent eosinophilia.
Internal and emergency medicine 2007;2(2):107-12.
2007: Gisella Volpe; Alessandro Cignetti; Cristina Panuzzo; Mirela Kuka; Katiuscia Vitaggio; Mara Brancaccio; Giuseppe Perrone; Monica Rinaldi; Giuseppina Prato; Milena Fava; Massimo Geuna; Marisa Pautasso; Claudia Casnici; Emanuela Signori; Giancarlo Tonon; Guido Tarone; Ornella Marelli; Vito Michele Fazio; Giuseppe Saglio
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Cancer research 2007;67(11):5300-7.
2007: Alessandro Morotti; Guido Parvis; Daniela Cilloni; U Familiari; Marisa Pautasso; M Bosa; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Renata Catalano; Valentina Rosso; Sonia Carturan; Enrico Bracco; Angelo Guerrasio; Giuseppe Saglio
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536.
Leukemia 2007;21(6):1305-6.
2007: Jelena V Jovanovic; Joannah Score; Katherine Waghorn; Daniela Cilloni; Enrico Gottardi; Georgia Metzgeroth; Philipp Erben; Helena Popp; Christoph Walz; Andreas Hochhaus; Catherine Roche-Lestienne; Claude Preudhomme; Ellen Solomon; Jane Apperley; Michela Rondoni; Emanuela Ottaviani; giovanni martinelli; Finella Brito-Babapulle; Giuseppe Saglio; Rüdiger Hehlmann; Nicholas C P Cross; Andreas Reiter; David Grimwade
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.
Blood 2007;109(11):4635-40.
2007: Jorge Cortes; Philippe Rousselot; Dong-Wook Kim; Ellen Ritchie; Nelson Hamerschlak; Steven Coutre; Andreas Hochhaus; françois guilhot; Giuseppe Saglio; Jane Apperley; Oliver G Ottmann; Neil Shah; Philipp Erben; Susan Branford; Prasheen Agarwal; Ashwin Gollerkeri; Michele Baccarani
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.
Blood 2007;109(8):3207-13.
2007: Simona Soverini; Sabrina Colarossi; Alessandra Gnani; Fausto Castagnetti; Gianantonio Rosti; Costanza Bosi; Stefania Paolini; Michela Rondoni; Pier Paolo Piccaluga; Francesca Palandri; Panagiota Giannoulia; Giulia Marzocchi; Simona Luatti; Nicoletta Testoni; Ilaria Iacobucci; Daniela Cilloni; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain.
Haematologica 2007;92(3):401-4.
2007: Tommasina Guglielmelli; Emilia Giugliano; Susanna Cappia; Mauro Papotti; Giuseppe Saglio
Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14).
Cancer genetics and cytogenetics 2007;173(1):51-6.
2007: Gianantonio Rosti; Ilaria Iacobucci; Simona Bassi; Fausto Castagnetti; Marilina Amabile; Daniela Cilloni; Angela Poerio; Simona Soverini; Francesca Palandri; Giovanna Rege-Cambrin; Franco Iuliano; Giuliana Alimena; Roberto Latagliata; Nicoletta Testoni; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party.
Haematologica 2007;92(1):101-5.
2006: Simona Soverini; Sabrina Colarossi; Alessandra Gnani; Gianantonio Rosti; Fausto Castagnetti; Angela Poerio; Ilaria Iacobucci; Marilina Amabile; Elisabetta Abruzzese; Ester Orlandi; Franca Radaelli; Fabrizio Ciccone; Mario Tiribelli; Roberto di Lorenzo; Clementina Caracciolo; Barbara Izzo; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7374-9.
2006: giovanni martinelli; Ilaria Iacobucci; Simona Soverini; Daniela Cilloni; Giuseppe Saglio; Fabrizio Pane; Michele Baccarani
Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management.
Hematological oncology 2006;24(4):196-204.
2006: Alessandro Morotti; Daniela Cilloni; Marisa Pautasso; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Renata Catalano; Valentina Rosso; A Chiarenza; Riccardo Taulli; Enrico Bracco; Giovanna Rege-Cambrin; Enrico Gottardi; Giuseppe Saglio
NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line.
American journal of hematology 2006;81(12):938-45.
2006: Simona Soverini; giovanni martinelli; Sabrina Colarossi; Alessandra Gnani; Fausto Castagnetti; Gianantonio Rosti; Costanza Bosi; Stefania Paolini; Michela Rondoni; Pier Paolo Piccaluga; Francesca Palandri; Panagiota Giannoulia; Giulia Marzocchi; Simona Luatti; Nicoletta Testoni; Ilaria Iacobucci; Daniela Cilloni; Giuseppe Saglio; Michele Baccarani
Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):e51-2.
2006: Daniela Cilloni; Emanuela Messa; Francesca Messa; Sonia Carturan; Ilaria Defilippi; Francesca Arruga; Valentina Rosso; Renata Catalano; Enrico Bracco; Paolo Nicoli; Giuseppe Saglio
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.
Annals of the New York Academy of Sciences 2006;1089():411-23.
2006: Susan Branford; Nicholas C P Cross; Andreas Hochhaus; Jerald P Radich; Giuseppe Saglio; Jaspal Kaeda; J Goldman; Timothy Hughes
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia.
Leukemia 2006;20(11):1925-30.
2006: Emilio Donti; Alfonso Zaccaria; Alessandra Bassetti; Giovanna Venti; Barbara Giannini; Paolo Prontera; Erika Bianchi; Anna Valenti; Giuseppe Saglio; Anna Marina Liberati
Occurrence of the same chromosome abnormalities in Ph+ and Ph- cells in chronic myeloid leukaemia. Evidence of a secondary origin of the Ph chromosome?
British journal of haematology 2006;135(2):265-6.
2006: Davide Rossi; Clara Deambrogi; Daniela Capello; Michaela Cerri; Monia Lunghi; Guido Parvis; Giuseppe Saglio; Gianluca Gaidano; Daniela Cilloni
JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders.
British journal of haematology 2006;135(2):267-8.
2006: Brunangelo Falini; Maria Paola Martelli; Niccolò Bolli; Rossella Bonasso; Emanuela Ghia; Maria Teresa Pallotta; Daniela Diverio; Ildo Nicoletti; Roberta Pacini; Alessia Tabarrini; Barbara Verducci Galletti; Roberta Mannucci; Giovanni Roti; Roberto Rosati; Giorgina Specchia; Arcangelo Liso; Enrico Tiacci; Myriam Alcalay; Lucilla Luzi; Sara Volorio; Loris Bernard; Anna Guarini; Sergio Amadori; Franco Mandelli; Fabrizio Pane; Francesco Lo Coco; Giuseppe Saglio; Pier Giuseppe Pelicci; Massimo F Martelli; Cristina Mecucci
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
Blood 2006;108(6):1999-2005.
2006: Michele Baccarani; Giuseppe Saglio; John Goldman; Andreas Hochhaus; Bengt Simonsson; Frederick Appelbaum; Jane Apperley; Francisco Cervantes; Jorge Cortes; Michael W N Deininger; Alois Gratwohl; françois guilhot; Mary Horowitz; Timothy Hughes; Andrew Lamb; Richard Larson; Dietger Niederwieser; Richard Silver; Rüdiger Hehlmann
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Blood 2006;108(6):1809-20.
2006: Timothy Hughes; Michael W N Deininger; Andreas Hochhaus; Susan Branford; Jerald P Radich; Jaspal Kaeda; Michele Baccarani; Jorge Cortes; Nicholas C P Cross; Brian J Druker; Jean Gabert; David Grimwade; Rüdiger Hehlmann; Suzanne Kamel-Reid; Jeffrey H Lipton; Janina Longtine; giovanni martinelli; Giuseppe Saglio; Simona Soverini; Wendy Stock; John M Goldman
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.
Blood 2006;108(1):28-37.
2006: Paolo Gorello; Giovanni Cazzaniga; F Alberti; Maria Grazia Dell'Oro; Enrico Gottardi; Giorgina Specchia; Giovanni Roti; Roberto Rosati; Massimo F Martelli; Daniela Diverio; Francesco Lo Coco; Andrea Biondi; Giuseppe Saglio; Cristina Mecucci; Brunangelo Falini
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations.
Leukemia 2006;20(6):1103-8.
2006: Ilaria Iacobucci; Giuseppe Saglio; Gianantonio Rosti; Nicoletta Testoni; Fabrizio Pane; Marilina Amabile; Angela Poerio; Simona Soverini; Simona Bassi; Daniela Cilloni; Renato Bassan; Massimo Breccia; Francesco Lauria; Barbara Izzo; Serena Merante; Francesco Frassoni; Stefania Paolini; Enrico Montefusco; Michele Baccarani; giovanni martinelli
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3037-42.
2006: Fabio Timeus; Nicoletta Crescenzio; Emanuela Ricotti; alessandra doria; Daniele Bertin; Giuseppe Saglio; Pier-Angelo Tovo
The effects of saquinavir on imatinib-resistant chronic myelogenous leukemia cell lines.
Haematologica 2006;91(5):711-2.
2006: Giuseppe Cimino; Fabrizio Pane; Loredana Elia; Erica Finolezzi; Paola Fazi; Luciana Annino; Giovanna Meloni; Marco Mancini; Alessandra Tedeschi; Francesco Di Raimondo; Giorgina Specchia; Giuseppe Fioritoni; Pietro Leoni; Antonio Cuneo; Cristina Mecucci; Giuseppe Saglio; Franco Mandelli; Robin Foà
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial.
Haematologica 2006;91(3):377-80.
2006: Alessandro Morotti; Daniela Cilloni; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Renata Catalano; Valentina Rosso; Annalisa Chiarenza; Chiara Pilatrino; Angelo Guerrasio; Riccardo Taulli; Enrico Bracco; Marisa Pautasso; Daniela Baraban; Enrico Gottardi; Giuseppe Saglio
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cells.
Cancer 2006;106(5):1188-96.
2006: giovanni martinelli; Ilaria Iacobucci; Gianantonio Rosti; Fabrizio Pane; Marilina Amabile; Fausto Castagnetti; Daniela Cilloni; Simona Soverini; Nicoletta Testoni; Giorgina Specchia; Serena Merante; Alfonso Zaccaria; F Frassoni; Giuseppe Saglio; Michele Baccarani
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(3):495-502.
2006: Alessandra Aloisi; Sandra Di Gregorio; Fabio Stagno; Patrizia Guglielmo; Francesca Mannino; Maria Pia Sormani; Paolo Bruzzi; Carlo Gambacorti-Passerini; Giuseppe Saglio; Salvatore Venuta; Rosario Giustolisi; Angelo Messina; Paolo Vigneri
BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B.
Blood 2006;107(4):1591-8.
2006: Ilaria Iacobucci; Gianantonio Rosti; Marilina Amabile; Angela Poerio; Simona Soverini; Daniela Cilloni; Nicoletta Testoni; Elisabetta Abruzzese; Enrico Montefusco; Emanuela Ottaviani; Franco Iuliano; Domenico Russo; marco gobbi; Giuliana Alimena; Bruno Martino; Carolina Terragna; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):454-9.
2006: Antonella Vitale; Anna Guarini; Cristina Ariola; Marco Mancini; Cristina Mecucci; Antonio Cuneo; Fabrizio Pane; Giuseppe Saglio; Giuseppe Cimino; Agostino Tafuri; Giovanna Meloni; Francesco Fabbiano; Anna Recchia; Maria Grazia Kropp; Mauro Krampera; Nicola Cascavilla; Felicetto Ferrara; Antonio Romano; Patrizio Mazza; Claudio Fozza; Francesca Paoloni; Marco Vignetti; Robin Foà
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.
Blood 2006;107(2):473-9.
2006: Tommasina Guglielmelli; Sara Capella; Giuseppe Saglio
Very low doses of thalidomide as single agent in relapsed/refractory multiple myeloma.
Acta haematologica 2006;116(1):70-1.
2006: Daniela Cilloni; Enrico Gottardi; Giuseppe Saglio
WT1 overexpression in acute myeloid leukemia and myelodysplastic syndromes.
Methods in molecular medicine 2006;125():199-211.
2006: Daniela Cilloni; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Alessandro Morotti; Emanuela Messa; Sonia Carturan; Emilia Giugliano; Marisa Pautasso; Enrico Bracco; Valentina Rosso; A Sen; giovanni martinelli; Michele Baccarani; Giuseppe Saglio
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance.
Leukemia 2006;20(1):61-7.
2005: Jürgen Groet; Claire Mulligan; Monica Spinelli; Anna Serra; Suzanne McElwaine; Finbarr E Cotter; Franca Dagna Bricarelli; Giuseppe Saglio; Giuseppe Basso; Dean Nizetic
Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome.
Blood 2005;106(5):1887-8.
2005: Chiara Pilatrino; Daniela Cilloni; Emanuela Messa; Alessandro Morotti; Emilia Giugliano; Marisa Pautasso; Ubaldo Familiari; Susanna Cappia; Pier Giuseppe Pelicci; Francesco Lo Coco; Giuseppe Saglio; Angelo Guerrasio
Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
Cancer 2005;104(1):101-9.
2005: Simona Soverini; giovanni martinelli; Gianantonio Rosti; Simona Bassi; Marilina Amabile; Angela Poerio; Barbara Giannini; Elena Trabacchi; Fausto Castagnetti; Nicoletta Testoni; Simona Luatti; Antonio de Vivo; Daniela Cilloni; Barbara Izzo; Milena Fava; Elisabetta Abruzzese; Daniele Alberti; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4100-9.
2005: Fabrizio Pane; G Cimino; Barbara Izzo; Andrea Camera; A Vitale; Concetta Quintarelli; Marco Picardi; G Specchia; M Mancini; A Cuneo; C Mecucci; giovanni martinelli; Giuseppe Saglio; Bruno Rotoli; F Mandelli; Francesco Salvatore; Robin Foà
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.
Leukemia 2005;19(4):628-35.
2005: Giovanna Rege-Cambrin; Emilia Giugliano; Lucienne Michaux; Michel Stul; Patrizia Scaravaglio; Anna Serra; Giuseppe Saglio; Anne Hagemeijer
Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes.
Haematologica 2005;90(2):262-4.
2005: Brunangelo Falini; Cristina Mecucci; Enrico Tiacci; Myriam Alcalay; Roberto Rosati; Laura Pasqualucci; Roberta La Starza; Daniela Diverio; Emanuela Colombo; Antonella Santucci; Barbara Bigerna; Roberta Pacini; Alessandra Pucciarini; Arcangelo Liso; Marco Vignetti; Paola Fazi; Natalia Meani; Valentina Pettirossi; Giuseppe Saglio; Franco Mandelli; Francesco Lo Coco; Pier Giuseppe Pelicci; Massimo F Martelli
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
The New England journal of medicine 2005;352(3):254-66.
2005: Michele Malagola; giovanni martinelli; Michela Rondoni; Stefania Paolini; Stavrula Gaitani; Mario Arpinati; Pier Paolo Piccaluga; Marilina Amabile; Constanza Basi; Emanuela Ottaviani; Anna Candoni; Enrico Gottardi; Daniela Cilloni; Monica Bocchia; Giuseppe Saglio; Francesco Lauria; Renato Fanin; Giuseppe Visani; Maria Carla Marrè; Michela Maderna; Francesca Rancati; Vincenza Vinaccia; Domenico Russo; Michele Baccarani
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
Blood 2005;105(2):904; author reply 905.
2005: Giuseppe Saglio; Sonia Carturan; Sara Grillo; Sara Capella; Francesca Arruga; Ilaria Defilippi; Valentina Rosso; Maria Rauco; Anna Marina Liberati; Daniela Cilloni
WT1 overexpression: a clinically useful marker in acute and chronic myeloid leukemias.
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():76-8.
2004: Michele Baccarani; giovanni martinelli; Gianantonio Rosti; Elena Trabacchi; Nicoletta Testoni; Simona Bassi; Marilina Amabile; Simona Soverini; Fausto Castagnetti; Daniela Cilloni; Barbara Izzo; Antonio de Vivo; Emanuela Messa; Francesca Bonifazi; Angela Poerio; Simona Luatti; Emilia Giugliano; Daniele Alberti; Gianluca Fincato; Domenico Russo; Fabrizio Pane; Giuseppe Saglio
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia.
Blood 2004;104(13):4245-51.
2004: Giuseppe Saglio; Alessandro Morotti; Giovanna Mattioli; Emanuela Messa; Emilia Giugliano; Gisella Volpe; Giovanna Rege-Cambrin; Daniela Cilloni
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia.
Annals of the New York Academy of Sciences 2004;1028():423-31.
2004: Daniela Cilloni; Francesca Messa; Sonia Carturan; Francesca Arruga; Ilaria Defilippi; Emanuela Messa; Enrico Gottardi; Giuseppe Saglio
Myelodysplastic syndromes.
Annals of the New York Academy of Sciences 2004;1028():400-8.
2004: Loredana Elia; E Gottardi; G Floriddia; Rita Grillo; F Ciambelli; M Luciani; P Chiusolo; R Invernizzi; Giovanna Meloni; Robin Foà; Giuseppe Saglio; Giuseppe Cimino
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia.
Leukemia 2004;18(11):1824-30.
2004: Daniela Cilloni; Francesca Messa; Enrico Gottardi; Milena Fava; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Emanuela Messa; Alessandro Morotti; Emilia Giugliano; Giovanna Rege-Cambrin; Daniele Alberti; Michele Baccarani; Giuseppe Saglio
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.
Cancer 2004;101(5):979-88.
2004: Giorgina Specchia; Francesco Albano; Luisa Anelli; Antonella Zagaria; Arcangelo Liso; Roberta La Starza; Marco Mancini; Lucia Sebastio; Emilia Giugliano; Giuseppe Saglio; Vincenzo Liso; Mariano Rocchi
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints.
Genes, chromosomes & cancer 2004;41(1):86-91.
2004: Simona Soverini; giovanni martinelli; Marilina Amabile; Angela Poerio; Michele Bianchini; Gianantonio Rosti; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani
Denaturing-HPLC-based assay for detection of ABL mutations in chronic myeloid leukemia patients resistant to Imatinib.
Clinical chemistry 2004;50(7):1205-13.
2004: Alessandro Levis; Daniela Pietrasanta; Laura Godio; Umberto Vitolo; Giorgio Ciravegna; Francesco Di Vito; Paolo Gavarotti; Tommasina Guglielmelli; Lorella Orsucci; Ermanno Raviolo; Fabrizio Salvi; Anna Tonso; Massimo Aglietta; Mario Boccadoro; Andrea Gallamini; Giuseppe Saglio; Enzo Scassa; Delia Rota Scalabrini; Eugenio Gallo
A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma.
Clinical lymphoma 2004;5(1):50-5.
2004: Giuseppe Saglio; Daniela Cilloni; Francesca Rancati; L Boano
Glivec and CML: a lucky date.
Journal of biological regulators and homeostatic agents 2004;18(2):246-51.
2004: Daniela Cilloni; Sonia Carturan; Enrico Gottardi; Francesca Messa; Milena Fava; Ilaria Defilippi; Francesca Arruga; Giuseppe Saglio
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients.
Blood 2004;103(6):2428; author reply 2429.
2004: Gianantonio Rosti; giovanni martinelli; Simona Bassi; Marilina Amabile; Elena Trabacchi; Barbara Giannini; Daniela Cilloni; Barbara Izzo; Antonio de Vivo; Nicoletta Testoni; Giovanna Rege Cambrin; Francesca Bonifazi; Simona Soverini; Simona Luatti; Enrico Gottardi; Daniele Alberti; Fabrizio Pane; Francesco Salvatore; Giuseppe Saglio; Michele Baccarani
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia.
Blood 2004;103(6):2284-90.
2004: Davide Rossi; Daniela Capello; Annunziata Gloghini; Silvia Franceschetti; Marco Paulli; Kishor Bhatia; Giuseppe Saglio; Umberto Vitolo; Stefano A Pileri; Manel Esteller; Antonino Carbone; Gianluca Gaidano
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.
Haematologica 2004;89(2):154-64.
2004: Daniela Cilloni; Giuseppe Saglio
WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome.
Acta haematologica 2004;112(1-2):79-84.
2004: Francesca Guidetti; Sandra Grazioli; Francesca Capelli; Claudia Marini; Margherita Gallicchio; Daniela De Micheli; Luigi Castello; Pier Paolo Sainaghi; Gian Paolo Fra; Giuseppe Saglio; Gian Carlo Avanzi
Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
Haematologica 2004;89(1):21-8.
2004: Giuseppe Saglio; Daniela Cilloni
Conventional and novel tools for defining the risk of the individual patient with chronic myeloid leukemia and for monitoring treatment.
Haematologica 2004;89(1):6-9.
2003: Jean Gabert; Emmanuel Beillard; V H J van der Velden; W Bi; David Grimwade; N Pallisgaard; G Barbany; Giovanni Cazzaniga; Jean-Michel Cayuela; H Cavé; Fabrizio Pane; J L E Aerts; D De Micheli; Xavier Thirion; Vincent Pradel; M González; Susanne Viehmann; Maria Malec; Giuseppe Saglio; Jacques J M van Dongen
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
Leukemia 2003;17(12):2318-57.
2003: Emmanuel Beillard; N Pallisgaard; V H J van der Velden; W Bi; R Dee; E van der Schoot; Eric Delabesse; Elizabeth Macintyre; Enrico Gottardi; Giuseppe Saglio; Franz Watzinger; Thomas Lion; Jacques J M van Dongen; Peter Hokland; Jean Gabert
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.
Leukemia 2003;17(12):2474-86.
2003: Daniela Cilloni; Sonia Carturan; Enrico Gottardi; Francesca Messa; Emanuela Messa; Milena Fava; Daniela Diverio; Angelo Guerrasio; Francesco Lo Coco; Giuseppe Saglio
Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias.
Blood 2003;102(7):2705-6.
2003: Giuseppe Cimino; Loredana Elia; Marco Mancini; Luciana Annino; Barbara Anaclerico; Paola Fazi; Antonella Vitale; Giorgina Specchia; Francesco Di Raimondo; Anna Recchia; Antonio Cuneo; Cristina Mecucci; Fabrizio Pane; Giuseppe Saglio; Robin Foa; Franco Mandelli
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome.
Blood 2003;102(6):2014-20.
2003: Daniela Cilloni; Enrico Gottardi; Milena Fava; Francesca Messa; Sonia Carturan; Alessandro Busca; Angelo Guerrasio; Giuseppe Saglio
Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection.
Blood 2003;102(2):773-4; author reply 774.
2003: Daniela Cilloni; Enrico Gottardi; Francesca Messa; Milena Fava; Patrizia Scaravaglio; Marilena Bertini; Mauro Girotto; Carlo Marinone; Dario Ferrero; Andrea Gallamini; Alessandro Levis; Giuseppe Saglio
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(10):1988-95.
2003: Daniela Cilloni; Giuseppe Saglio
Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy.
Seminars in hematology 2003;40(2 Suppl 2):37-41.
2003: Stephen G O'Brien; françois guilhot; Richard A Larson; Insa Gathmann; Michele Baccarani; Francisco Cervantes; Jan J Cornelissen; Thomas Fischer; Andreas Hochhaus; Timothy Hughes; Klaus Lechner; Johan Lanng Nielsen; Philippe Rousselot; Josy Reiffers; Giuseppe Saglio; John Shepherd; Bengt Simonsson; Alois Gratwohl; John M Goldman; Andrew Lamb; Kerry Taylor; Gregor Verhoef; Ann E Bolton; Renaud Capdeville; Brian J Druker
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
The New England journal of medicine 2003;348(11):994-1004.
2003: Gianantonio Rosti; Elena Trabacchi; Simona Bassi; Francesca Bonifazi; Antonio de Vivo; giovanni martinelli; Daniele Alberti; Gianluca Fincato; Giuseppe Saglio; Michele Baccarani
Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia.
Haematologica 2003;88(3):256-9.
2003: Robin Foa; Antonella Vitale; Marco Mancini; Antonio Cuneo; Cristina Mecucci; Loredana Elia; Rosario Lombardo; Giuseppe Saglio; Giuseppe Torelli; Luciana Annino; Giorgina Specchia; Eugenio Damasio; Anna Recchia; Francesco Di Raimondo; Enrica Morra; Ettore Volpe; Agostino Tafuri; Paola Fazi; Stephen P Hunger; Franco Mandelli
E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features.
British journal of haematology 2003;120(3):484-7.
2002: Emilia Giugliano; Giovanna Rege-Cambrin; Patrizia Scaravaglio; Iwona Wlodarska; Betty Emanuel; Michel Stul; Anna Serra; Anna Tonso; Massimo Pini; Giuseppe Saglio; Anne Hagemeijer
Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias.
Haematologica 2002;87(10):1014-20.
2002: Daniela Cilloni; Enrico Gottardi; D De Micheli; Anna Serra; Gisella Volpe; Francesca Messa; Giovanna Rege-Cambrin; Angelo Guerrasio; Mariadomenica Divona; Francesco Lo Coco; Giuseppe Saglio
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients.
Leukemia 2002;16(10):2115-21.
2002: Mar Bellido; Daniela Capello; Albert Altés; Camino Estivill; Gianluca Gaidano; Ramón Pujol; Ramón Bordes; Montserrat Baiget; Giuseppe Saglio; Jorge Sierra; Josep F Nomdedéu
Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
Haematologica 2002;87(9):908-17.
2002: Antonio Cuneo; Renato Bigoni; francesco cavazzini; Antonella Bardi; Maria Grazia Roberti; Paola Agostini; Elisa Tammiso; N Ciccone; Marco Mancini; Mauro Nanni; R De Cuia; Mariadomenica Divona; Roberta La Starza; Barbara Crescenzi; Nicoletta Testoni; Giovanna Rege-Cambrin; Cristina Mecucci; Francesco Lo Coco; Giuseppe Saglio; Gianluigi Castoldi
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Leukemia 2002;16(9):1745-51.
2002: Josep F Nomdedéu; Adriana Lasa; Josep Ubeda; Giuseppe Saglio; Mar Bellido; Sílvia Casas; Maria J Carnicer; Anna Aventín; Anna Sureda; Jorge Sierra; Montserrat Baiget
Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A genotypic study.
Haematologica 2002;87(8):828-35.
2002: Giuseppe Saglio; Clelia Tiziana Storlazzi; Emilia Giugliano; Cecilia Surace; Luisa Anelli; Giovanna Rege-Cambrin; Antonella Zagaria; Antonio Jimenez Velasco; Anabel Heiniger; Patrizia Scaravaglio; Antoni Torres Gomez; Jose Roman-Gomez; Nicoletta Archidiacono; Sandro Banfi; Mariano Rocchi
A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia chromosome translocation.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(15):9882-7.
2002: giovanni martinelli; Marilina Amabile; Barbara Giannini; Carolina Terragna; Emanuela Ottaviani; Simona Soverini; Giuseppe Saglio; Gianantonio Rosti; Michele Baccarani
Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one.
Haematologica 2002;87(7):688-94; discussion 694.
2002: Daniela Cilloni; Angelo Guerrasio; Emilia Giugliano; Patrizia Scaravaglio; Gisella Volpe; Giovanna Rege-Cambrin; Giuseppe Saglio
From genes to therapy: the case of Philadelphia chromosome-positive leukemias.
Annals of the New York Academy of Sciences 2002;963():306-12.
2002: Angelo Guerrasio; Chiara Pilatrino; D De Micheli; Daniela Cilloni; Anna Serra; Enrico Gottardi; A Parziale; Filippo Marmont; Daniela Diverio; Mariadomenica Divona; Francesco Lo Coco; Giuseppe Saglio
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
Leukemia 2002;16(6):1176-81.
2002: Srdan Verstovsek; Hui Lin; Andrew Lamb; Giuseppe Saglio; Daniela De Micheli; Fabrizio Pane; Guillermo Garcia-Manero; Mariano Intrieri; Bruno Rotoli; Francesco Salvatore; Jie Qiang Guo; Moshe Talpaz; Giorgina Specchia; Giovanni Pizzolo; Anna Marina Liberati; Jorge Cortes; Robert C Quackenbush; Ralph B Arlinghaus
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course.
Cancer 2002;94(9):2416-25.
2002: Chiara Pilatrino; Aldo Cataldi; Angelo Guerrasio; Giuseppe Saglio
Renal Hodgkin's disease.
British journal of haematology 2002;116(4):732.
2002: Michele Baccarani; Gianantonio Rosti; Antonio de Vivo; Francesca Bonifazi; Domenico Russo; giovanni martinelli; Nicoletta Testoni; Marilina Amabile; Mauro Fiacchini; Enrico Montefusco; Giuseppe Saglio; Sante Tura
A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.
Blood 2002;99(5):1527-35.
2002: Patrizia Scaravaglio; Tommasina Guglielmelli; Emilia Giugliano; Filippo Marmont; Ernesta Audisio; Eugenio Gallo; Giuseppe Saglio; Giovanna Rege-Cambrin
Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation.
Cancer genetics and cytogenetics 2002;133(1):98-101.
2002: Umberto Vitolo; Barbara Botto; Daniela Capello; Daniela Vivenza; Vittorina Zagonel; Annunziata Gloghini; Domenico Novero; Guido Parvis; Roberta Calvi; Cristiano Ariatti; I Milan; Marilena Bertini; Carola Boccomini; R Freilone; Patrizia Pregno; Lorella Orsucci; Giorgio Palestro; Giuseppe Saglio; Antonino Carbone; Eugenio Gallo; Gianluca Gaidano
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.
Leukemia 2002;16(2):268-75.
2002: Massimo Pini; Enrico Gottardi; Patrizia Scaravaglio; Emilia Giugliano; Roberta Libener; Anna Baraldi; Alberto Muzio; Elisa Cornaglia; Giuseppe Saglio; Alessandro Levis
A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(6):315-6.
2002: Aldo Cataldi; Patrizia Sardo; Giancarlo Ventilii; Angelo Guerrasio; Chiara Pilastrino; Giuseppe Saglio; Cesare Fava
Extranodal Hodgkin lymphoma with renal, splenic and uterine involvement. A case report.
La Radiologia medica 2002;103(1-2):130-3.
2002: Roberta La Starza; Antonella Vitale; Anna Serra; Giuseppe Saglio; Giuseppe Fioritoni; Daniela Falzetti; Massimo F Martelli; Robin Foà; Cristina Mecucci
Philadelphia-positive acute lymphoblastic leukemia with multiple subclones including duplication of the Philadelphia chromosome and Abelson oncogene.
Cancer genetics and cytogenetics 2002;132(1):46-50.
2001: Francesca Bonifazi; Antonio de Vivo; Gianantonio Rosti; françois guilhot; Joëlle Guilhot; Elena Trabacchi; Rüdiger Hehlmann; A Hochhaus; P C Shepherd; Juan Luis Steegmann; Hanneke C Kluin-Nelemans; J Thaler; B Simonsson; A Louwagie; J Reiffers; François-Xavier Mahon; Enrico Montefusco; Giuliana Alimena; Joerg Hasford; S Richards; Giuseppe Saglio; Nicoletta Testoni; giovanni martinelli; Sante Tura; Michele Baccarani
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders.
Blood 2001;98(10):3074-81.
2001: Emilia Giugliano; Giovanna Rege-Cambrin; Patrizia Scaravaglio; Anna Serra; Iwona Wlodarska; B Emanuel; Giuseppe Saglio; Anne Hagemeijer
MLL-AF6 fusion resulting from a new three-way translocation t(6;11;7) in a patient with acute myeloid leukemia.
Leukemia 2001;15(10):1674-6.
2001: Stefano Sacchi; Massimo Federico; Umberto Vitolo; Carola Boccomini; Daniele Vallisa; Luca Baldini; M Petrini; Serena Rupoli; Francesco Di Raimondo; Francesco Merli; V Liso; A Tabilio; Giuseppe Saglio; G Vinci; Maura Brugiatelli; Giuseppe Dastoli
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma.
Haematologica 2001;86(9):951-8.
2001: Marilina Amabile; Barbara Giannini; Nicoletta Testoni; Vittorio Montefusco; Gianantonio Rosti; C Zardini; Carolina Terragna; Silvia Buonamici; Emanuela Ottaviani; Simona Soverini; Mauro Fiacchini; Simona Bassi; Antonio de Vivo; Elena Trabacchi; Giuseppe Saglio; Fabrizio Pane; Michele Baccarani; Sante Tura; giovanni martinelli
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.
Haematologica 2001;86(3):252-9.
2001: Monica Rinaldi; F Ria; Paola Parrella; Emanuela Signori; A Serra; Silvia Anna Ciafrè; I Vespignani; M Lazzari; Maria Giulia Farace; Giuseppe Saglio; Vito Michele Fazio
Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Cancer research 2001;61(4):1555-62.
2000: J Roman; A Parziale; Enrico Gottardi; D De Micheli; Daniela Cilloni; Mario Tiribelli; Maria Gracia Gonzalez; M del Carmen Rodriguez; Antonio Torres; Giuseppe Saglio
Novel type of BCR-ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantation.
British journal of haematology 2000;111(2):644-6.
2000: Lucia Fassone; Gianluca Gaidano; Cristiano Ariatti; Daniela Vivenza; Daniela Capello; Annunziata Gloghini; AM Cilia; Daniela Buonaiuto; Davide Rossi; C Pastore; Antonino Carbone; Giuseppe Saglio
The role of cytokines in the pathogenesis and management of AIDS-related lymphomas.
Leukemia & lymphoma 2000;38(5-6):481-8.
2000: Cristiano Ariatti; Daniela Vivenza; Daniela Capello; Anna Migliazza; Guido Parvis; Lucia Fassone; Daniela Buonaiuto; F Savinelli; Davide Rossi; Giuseppe Saglio; Gianluca Gaidano
Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: pathogenetic and histogenetic implications.
Human pathology 2000;31(7):871-3.
2000: Mario Tiribelli; Anna Tonso; D Ferrro; A Parzilae; G R Cambrin; Patrizia Scaravaglio; Daniela Cilloni; Enrico Gottardi; Giuseppe Saglio
Lack of SH3 domain does not imply a more severe clinical course in Ph+ chronic myeloid leukemia patients.
Blood 2000;95(12):4019-20.
2000: giovanni martinelli; Vittorio Montefusco; Nicoletta Testoni; Marilina Amabile; Giuseppe Saglio; Emanuela Ottaviani; Carolina Terragna; Francesca Bonifazi; Gianantonio Rosti; Giuseppe Bandini; Sante Tura
Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
Haematologica 2000;85(6):653-8.
2000: giovanni martinelli; Nicoletta Testoni; Marilina Amabile; Francesca Bonifazi; Antonio de Vivo; P Farabegoli; Carolina Terragna; Vittorio Montefusco; Emanuela Ottaviani; Giuseppe Saglio; Domenico Russo; Michele Baccarani; Gianantonio Rosti; Sante Tura
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
Bone marrow transplantation 2000;25(7):729-36.
2000: Daniela Capello; Gianluca Gaidano; Margherita Gallicchio; Annunziata Gloghini; E Medico; Daniela Vivenza; Daniela Buonaiuto; Lucia Fassone; Gian Carlo Avanzi; Giuseppe Saglio; M Prat; Antonino Carbone
The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma.
Leukemia 2000;14(2):285-91.
2000: Lucia Fassone; K Bhatia; M Gutierrez; Daniela Capello; Annunziata Gloghini; Riccardo Dolcetti; Daniela Vivenza; V Ascoli; F Lo Coco; L Pagani; G Dotti; A Rambaldi; M Raphael; Umberto Tirelli; Giuseppe Saglio; I T Magrath; Antonino Carbone; Gianluca Gaidano
Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma.
Leukemia 2000;14(2):271-7.
2000: Gianluca Gaidano; Daniela Vivenza; Francesco Forconi; Daniela Capello; Annunziata Gloghini; K Bhatia; M Gutierrez; Margherita Gallicchio; Gian Carlo Avanzi; Lucia Fassone; Cristiano Ariatti; Daniela Buonaiuto; Antonella Cingolani; Giuseppe Saglio; Umberto Tirelli; Luigi Maria Larocca; Riccardo Dalla-Favera; Antonino Carbone
Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
Genes, chromosomes & cancer 2000;27(2):177-82.
2000: Daniela Capello; Umberto Vitolo; Laura Pasqualucci; S Quattrone; Giuseppe Migliaretti; Lucia Fassone; Cristiano Ariatti; Daniela Vivenza; Annunziata Gloghini; C Pastore; C Lanza; J Nomdedeu; Barbara Botto; R Freilone; Daniela Buonaiuto; Vittorina Zagonel; Eugenio Gallo; Giorgio Palestro; Giuseppe Saglio; Riccardo Dalla-Favera; Antonino Carbone; Gianluca Gaidano
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia.
Blood 2000;95(2):651-9.
2000: Anna Migliazza; Eftihia Cayanis; F Bosch-Albareda; H Komatsu; Stefano Martinotti; Elena Toniato; Sergey Kalachikov; MF Bonaldo; P Jelene; X Ye; Andrey Rzhetsky; X Qu; Minchen Chien; Giorgio Inghirami; Gianluca Gaidano; Umberto Vitolo; Giuseppe Saglio; Luigi Resegotti; P Zhang; MB Soares; J Russo; SG Fischer; IS Edelman; Argiris Efstratiadis; Riccardo Dalla-Favera
Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.
Current topics in microbiology and immunology 2000;252():275-84.
2000: giovanni martinelli; Carolina Terragna; Marilina Amabile; Vittorio Montefusco; Nicoletta Testoni; Emanuela Ottaviani; Antonio de Vivo; AM Mianulli; Giuseppe Saglio; Sante Tura
Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
Haematologica 2000;85(1):40-6.
2000: Giuseppe Cimino; Loredana Elia; Maria Cristina Rapanotti; T Sprovieri; Marco Mancini; Antonio Cuneo; Cristina Mecucci; Giuseppe Fioritoni; M Carotenuto; E Morra; Vincenzo Liso; Luciana Annino; Giuseppe Saglio; Giulio De Rossi; Robin Foà; Franco Mandelli
A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia.
Blood 2000;95(1):96-101.
1999: Jacques J M van Dongen; Elizabeth Macintyre; Jean Gabert; Eric Delabesse; V Rossi; Giuseppe Saglio; Enrico Gottardi; A Rambaldi; G Dotti; F Griesinger; A Parreira; Paula Gameiro; M G Diáz; Maria Malec; Anton Langerak; JF San Miguel; Andrea Biondi
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.
Leukemia 1999;13(12):1901-28.
1999: giovanni martinelli; Carolina Terragna; Marilina Amabile; Vittorio Montefusco; Nicoletta Testoni; Emanuela Ottaviani; Antonio de Vivo; AM Mianulli; Elena Trabacchi; Giuseppe Saglio; Sante Tura
Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2)
Leukemia 1999;13(10):1635-7.
1999: G Martinelli; Marilina Amabile; Carolina Terragna; Nicoletta Testoni; Emanuela Ottaviani; Vittorio Montefusco; Antonio de Vivo; M Baccarani; P Ricci; Giuseppe Saglio; S Tura
Concomitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patient.
Leukemia 1999;13(9):1463-4.
1999: Giovanna Meloni; Domenico Russo; Michele Baccarani; Nicoletta Testoni; giovanni martinelli; Renato Fanin; Elisa Zuffa; Gianantonio Rosti; Giuliana Alimena; Giuseppe Saglio; Franco Mandelli; Sante Tura
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
Haematologica 1999;84(8):707-15.
1999: Gianluca Gaidano; Daniela Capello; Annunziata Gloghini; Lucia Fassone; Daniela Vivenza; Cristiano Ariatti; Anna Migliazza; Giuseppe Saglio; Antonino Carbone
Frequent mutation of bcl-6 proto-oncogene in high grade, but not low grade, MALT lymphomas of the gastrointestinal tract.
Haematologica 1999;84(7):582-8.
1999: Giuseppe Saglio; Fabrizio Pane; G Martinelli; Angelo Guerrasio
BCR/ABL rearrangement and leukemia phenotype.
Leukemia 1999;13 Suppl 1():S96.
1999: Andrea Antinori; Luigi Maria Larocca; Lucia Fassone; P Cattani; Daniela Capello; Antonella Cingolani; Giuseppe Saglio; Giovanni Fadda; Gianluca Gaidano; L Ortona
HHV-8/KSHV is not associated with AIDS-related primary central nervous system lymphoma.
Brain pathology (Zurich, Switzerland) 1999;9(2):199-208.
1999: Gianluca Gaidano; Daniela Capello; AM Cilia; Annunziata Gloghini; Tiziana Perin; S Quattrone; Anna Migliazza; F Lo Coco; Giuseppe Saglio; V Ascoli; Antonino Carbone
Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis.
Genes, chromosomes & cancer 1999;24(1):16-23.
1998: C Pastore; Gianluca Gaidano; P Ghia; Lucia Fassone; AM Cilia; Annunziata Gloghini; Daniela Capello; Daniela Buonaiuto; S Gonella; silvio Roncella; Antonino Carbone; Giuseppe Saglio
Patterns of cytokine expression in AIDS-related non-Hodgkin's lymphoma.
British journal of haematology 1998;103(1):143-9.
1998: Gianluca Gaidano; Daniela Capello; Annunziata Gloghini; C Pastore; Anna Migliazza; S Quattrone; F Savinelli; Daniela Buonaiuto; AM Cilia; Tiziana Perin; Laura Pasqualucci; Vincenzo Canzonieri; Giuseppe Saglio; Riccardo Dalla-Favera; Antonino Carbone
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications.
Leukemia & lymphoma 1998;31(1-2):39-46.
1998: Luigi Maria Larocca; Daniela Capello; Alessandro Rinelli; S Nori; A Antinori; Annunziata Gloghini; A Cingolani; Anna Migliazza; Giuseppe Saglio; S Cammilleri-Broet; M Raphael; Antonino Carbone; Gianluca Gaidano
The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.
Blood 1998;92(3):1011-9.
1998: Daniela Diverio; V Rossi; Giuseppe Avvisati; Silvia De Santis; A Pistilli; Fabrizio Pane; Giuseppe Saglio; G Martinelli; Maria Concetta Petti; A Santoro; P G Pelicci; Franco Mandelli; Andrea Biondi; Francesco Lo Coco
Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial.
Blood 1998;92(3):784-9.
1998: giovanni martinelli; Nicoletta Testoni; Vittorio Montefusco; Marilina Amabile; Giuseppe Saglio; Emanuela Ottaviani; Carolina Terragna; F Bonifazzi; Antonio de Vivo; Fabrizio Pane; Gianantonio Rosti; Sante Tura
Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis.
Haematologica 1998;83(7):593-601.
1998: Josep F Nomdedéu; Montserrat Baiget; Gianluca Gaidano; Camino Estivill; Adriana Lasa; Enriqueta Rubiol; R Mateu; Ramón Bordes; Salut Brunet; Giuseppe Saglio; J Soler
p53 mutation in a case of blastic transformation of follicular lymphoma with double bcl-2 rearrangement (MBR and VCR).
Leukemia & lymphoma 1998;29(5-6):595-605.
1998: Gian Carlo Avanzi; Margherita Gallicchio; Flavia Bottarel; Loretta Gammaitoni; Giuliana Cavalloni; Donatella Buonfiglio; M Bragardo; G Bellomo; E Albano; Roberto Fantozzi; Giovanni Garbarino; Brian Varnum; Massimo Aglietta; Giuseppe Saglio; Umberto Dianzani; Chiara Dianzani
GAS6 inhibits granulocyte adhesion to endothelial cells.
Blood 1998;91(7):2334-40.
1998: Monica Rinaldi; Silvia Anna Ciafrè; Paola Parrella; Emanuela Signori; Maria Giulia Farace; Giuseppe Saglio; Vito Michele Fazio
Strategies to elicit anti-idiotypic immune response in B-lymphoma patients. Peptide and genetic immunization.
Advances in experimental medicine and biology 1998;451():323-30.
1998: Umberto Vitolo; Gianluca Gaidano; Barbara Botto; G Volpe; E Audisio; Marilena Bertini; Roberta Calvi; R Freilone; Domenico Novero; Lorella Orsucci; C Pastore; Daniela Capello; Guido Parvis; C Sacco; Vittorina Zagonel; Antonino Carbone; U Mazza; Giorgio Palestro; Giuseppe Saglio; Luigi Resegotti
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(1):55-61.
1997: Gianluca Gaidano; Annunziata Gloghini; Valter Gattei; M F Rossi; AM Cilia; C Godeas; Massimo Degan; Tiziana Perin; Vincenzo Canzonieri; Donatella Aldinucci; Giuseppe Saglio; Antonino Carbone; Antonio Pinto
Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen.
Blood 1997;90(12):4894-900.
1997: Gianluca Gaidano; C Pastore; Daniela Capello; V Cilli; Giuseppe Saglio
Molecular pathways in low grade B-cell lymphoma.
Leukemia & lymphoma 1997;26 Suppl 1():107-13.
1997: Gianluca Gaidano; G Volpe; C Pastore; Roberto Chiarle; Daniela Capello; Annunziata Gloghini; E Perissinotto; F Savinelli; M Bosco; U Mazza; S Pileri; Giorgio Palestro; Antonino Carbone; Giuseppe Saglio
Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomas.
American journal of hematology 1997;56(4):206-13.
1997: Daniela Capello; Antonino Carbone; C Pastore; Annunziata Gloghini; Giuseppe Saglio; Gianluca Gaidano
Point mutations of the BCL-6 gene in Burkitt's lymphoma.
British journal of haematology 1997;99(1):168-70.
1997: D Petroni; Giuseppe Saglio
Minimal residual disease in B-lymphoproliferative disorders by PCR detection of immunoglobulin heavy chain gene recombination.
Scandinavian journal of clinical and laboratory investigation 1997;57(6):541-7.
1997: Gianluca Gaidano; C Pastore; Annunziata Gloghini; Vincenzo Canzonieri; Daniela Capello; S Franceschi; Giuseppe Saglio; Antonino Carbone
Genetic heterogeneity of AIDS-related small non-cleaved cell lymphoma.
British journal of haematology 1997;98(3):726-32.
1997: Gianluca Gaidano; C Pastore; Valeria Santini; J Nomdedeu; B Gamberi; Daniela Capello; F Vischia; Luigi Resegotti; U Mazza; Pierluigi Rossi Ferrini; Francesco Lo Coco; Giuseppe Saglio
Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia.
Genes, chromosomes & cancer 1997;19(4):250-5.
1997: Franco Mandelli; Daniela Diverio; Giuseppe Avvisati; A Luciano; Tiziano Barbui; C Bernasconi; Giorgio Broccia; Raffaella Cerri; Michele Falda; Giuseppe Fioritoni; Franco Leoni; Vincenzo Liso; Maria Concetta Petti; Francesco Rodeghiero; Giuseppe Saglio; Maria Luce Vegna; Giuseppe Visani; Ulrich Jehn; Rein Willemze; Petra Muus; Pier Giuseppe Pelicci; Andrea Biondi; Francesco Lo Coco
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.
Blood 1997;90(3):1014-21.
1997: Giuseppe Saglio; F Pane; G Martinelli; A Guerrasio
BCR/ABL transcripts and leukemia phenotype: an unsolved puzzle.
Leukemia & lymphoma 1997;26(3-4):281-6.
1997: Sergey Kalachikov; Anna Migliazza; Eftihia Cayanis; N S Fracchiolla; MF Bonaldo; Lee N Lawton; P Jelenc; X Ye; X Qu; Minchen Chien; RS Hauptschein; Gianluca Gaidano; Umberto Vitolo; Giuseppe Saglio; Luigi Resegotti; V Brodjansky; N Yankovsky; P Zhang; MB Soares; J Russo; IS Edelman; Argiris Efstratiadis; Riccardo Dalla-Favera; SG Fischer
Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia.
Genomics 1997;42(3):369-77.
1997: Gianluca Gaidano; C Pastore; Annunziata Gloghini; Daniela Capello; U Tirelli; Giuseppe Saglio; Antonino Carbone
Microsatellite instability in KSHV/HHV-8 positive body-cavity-based lymphoma.
Human pathology 1997;28(6):748-50.
1997: C Lanza; Gisella Volpe; Giuseppe Basso; Enrico Gottardi; F Perfetto; V Cilli; M Spinelli; Emanuela Ricotti; Angelo Guerrasio; Enrico Madon; Giuseppe Saglio
The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome.
Leukemia 1997;11(6):820-1.
1997: Gianluca Gaidano; Antonino Carbone; C Pastore; Daniela Capello; Anna Migliazza; Annunziata Gloghini; silvio Roncella; M Ferrarini; Giuseppe Saglio; Riccardo Dalla-Favera
Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
Blood 1997;89(10):3755-62.
1997: C Lanza; Gisella Volpe; Giuseppe Basso; Enrico Gottardi; Elena Barisone; M Spinelli; Emanuela Ricotti; V Cilli; F Perfetto; Enrico Madon; Giuseppe Saglio
Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia.
British journal of haematology 1997;97(2):460-2.
1997: Gianluca Gaidano; Daniela Capello; C Pastore; A Antinori; Annunziata Gloghini; Antonino Carbone; L M Larocca; Giuseppe Saglio
Analysis of human herpesvirus type 8 infection in AIDS-related and AIDS-unrelated primary central nervous system lymphoma.
The Journal of infectious diseases 1997;175(5):1193-7.
1997: Angelo Guerrasio; Anna Serra; Enrico Gottardi; Daniela Cilloni; F Vischia; Guido Parvis; V Cilli; Giuseppe Saglio
Molecular events in chronic myeloid leukemia progression.
Leukemia 1997;11 Suppl 3():519-21.
1997: Giuseppe Cimino; C Lanza; Loredana Elia; Francesco Lo Coco; Gianluca Gaidano; Andrea Biondi; C Pastore; A Serra; E Canaani; C M Croce; Franco Mandelli; Giuseppe Saglio
Multigenetic lesions in infant acute leukaemias: correlations with ALL-1 gene status.
British journal of haematology 1997;96(2):308-13.
1997: Gianluca Gaidano; C Pastore; Daniela Capello; Anna Migliazza; Annunziata Gloghini; Giuseppe Saglio; Antonino Carbone; Riccardo Dalla-Favera
Involvement of the bcl-6 gene in AIDS-related lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():105-8.
1997: Gianluca Gaidano; C Pastore; Annunziata Gloghini; G Volpe; Daniela Capello; P Polito; E Vaccher; U Tirelli; Giuseppe Saglio; Antonino Carbone
Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia.
Leukemia & lymphoma 1997;24(3-4):257-66.
1997: Antonino Carbone; Gianluca Gaidano; Annunziata Gloghini; C Pastore; Giuseppe Saglio; Umberto Tirelli; R Dalla-Favera; B Falini
BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression.
The American journal of pathology 1997;150(1):155-65.
1996: Gianluca Gaidano; M Contarini; C Pastore; Giuseppe Saglio; Lina Matera
AIDS-related Burkitt's-type lymphomas are a target for lymphokine-activated killers induced by interleukin-2 and prolactin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1996;213(2):196-205.
1996: Giuseppina Barrera; Stefania Pizzimenti; A Serra; Carlo Ferretti; Vito Michele Fazio; Giuseppe Saglio; Mario U Dianzani
4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells.
Biochemical and biophysical research communications 1996;227(2):589-93.
1996: Fabrizio Pane; Ferdinando Frigeri; M Sindona; Luigiana Luciano; Felicetto Ferrara; R Cimino; G Meloni; Giuseppe Saglio; Francesco Salvatore; Bruno Rotoli
Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)
Blood 1996;88(7):2410-4.
1996: Gianluca Gaidano; C Pastore; Annunziata Gloghini; M Cusini; Josep F Nomdedéu; Gisella Volpe; Daniela Capello; E Vaccher; Ramón Bordes; U Tirelli; Giuseppe Saglio; Antonino Carbone
Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia.
AIDS (London, England) 1996;10(9):941-9.
1996: C Pastore; Antonino Carbone; Annunziata Gloghini; Gisella Volpe; Giuseppe Saglio; Gianluca Gaidano
Association of 6q deletions with AIDS-related diffuse large cell lymphoma.
Leukemia 1996;10(6):1051-3.
1996: Gisella Volpe; Umberto Vitolo; A Carbone; C Pastore; Marilena Bertini; Barbara Botto; E Audisio; R Freilone; Domenico Novero; Susanna Cappia; Paolo De Giuli; U Mazza; Luigi Resegotti; Giorgio Palestro; Giuseppe Saglio; Gianluca Gaidano
Molecular heterogeneity of B-lineage diffuse large cell lymphoma.
Genes, chromosomes & cancer 1996;16(1):21-30.
1996: C Lanza; Enrico Gottardi; Gianluca Gaidano; C Vivenza; A Parziale; F Perfetto; M Fornaci; Elena Barisone; Enrico Madon; Giuseppe Basso; Giuseppe Saglio
Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome.
Leukemia research 1996;20(5):441-3.
1996: Gisella Volpe; B Gamberi; C Pastore; Antonella Roetto; M Pautasso; Guido Parvis; C Camaschella; U Mazza; Giuseppe Saglio; Gianluca Gaidano
Analysis of microsatellite instability in chronic lymphoproliferative disorders.
Annals of hematology 1996;72(2):67-71.
1996: Giuseppe Saglio; Fabrizio Pane; Enrico Gottardi; Ferdinando Frigeri; M R Buonaiuto; Angelo Guerrasio; D de Micheli; A Parziale; M N Fornaci; giovanni martinelli; Francesco Salvatore
Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis.
Blood 1996;87(3):1075-80.
1996: Maria Alessandra Santucci; Giuseppe Saglio; Sante Tura
Pathogenesis and progression of chronic myeloid leukemia.
Haematologica 1996;81(1):63-76.
1996: C Lanza; Gianluca Gaidano; Giuseppe Cimino; C Pastore; J Nomdedeu; Gisella Volpe; C Vivenza; Guido Parvis; U Mazza; Giuseppe Basso; Enrico Madon; Francesco Lo Coco; Giuseppe Saglio
Distribution of TP53 mutations among acute leukemias with MLL rearrangements.
Genes, chromosomes & cancer 1996;15(1):48-53.
1996: Gianluca Gaidano; C Pastore; Annunziata Gloghini; Gisella Volpe; P Ghia; Giuseppe Saglio; Antonino Carbone
AIDS-related non-Hodgkin's lymphomas: molecular genetics, viral infection and cytokine deregulation.
Acta haematologica 1996;95(3-4):193-8.
1995: C Pastore; Annunziata Gloghini; Gisella Volpe; J Nomdedeu; E Leonardo; U Mazza; Giuseppe Saglio; A Carbone; Gianluca Gaidano
Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain.
British journal of haematology 1995;91(4):918-20.
1995: A Serra; Enrico Gottardi; F Della Ragione; Giuseppe Saglio; A Iolascon
Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia.
British journal of haematology 1995;91(3):625-9.
1995: C Pastore; J Nomdedeu; Gisella Volpe; Angelo Guerrasio; G R Cambrin; Guido Parvis; M Pautasso; C Daglio; U Mazza; Giuseppe Saglio
Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders.
Genes, chromosomes & cancer 1995;14(2):106-11.
1995: Angelo Guerrasio; C Rosso; giovanni martinelli; Francesco Lo Coco; M Pampinella; A Santoro; C Lanza; B Allione; Luigi Resegotti; Giuseppe Saglio
Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission.
British journal of haematology 1995;90(2):364-8.
1995: P Scaravaglio; Giuseppe Saglio; Massimo Geuna; Giorgio Palestro; T Guglielmelli; G Rege-Cambrin
Isochromosome 6p and deletion of 6q characterize two related cytogenetic clones in a patient with immunoblastic lymphoma.
Cancer genetics and cytogenetics 1995;81(2):179-81.
1995: Antonino Carbone; Annunziata Gloghini; Gianluca Gaidano; AM Cilia; P Bassi; P Polito; Emanuela Vaccher; Giuseppe Saglio; Umberto Tirelli
AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens.
American journal of clinical pathology 1995;103(5):561-7.
1995: Giuseppe Saglio
Minimal residual disease detection in human leukemias: biologic and clinical significance.
Acta haematologica Polonica 1995;26(2 Suppl 1):19-24.
1994: Gianluca Gaidano; C Pastore; C Lanza; U Mazza; Giuseppe Saglio
Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity.
Annals of hematology 1994;69(6):281-90.
1994: PM Richiardi; Roberto Tosi; G Martinelli; Giuseppe Saglio; Roberto Conte; M Barbanti; Anna Maria Dall'Omo; P Farabegoli; B Favoino; C Gambelunghe
The HLA class I-CML association revisited taking into account the two forms of gene fusion in the Philadelphia chromosome. A multicenter study.
Leukemia 1994;8(12):2134-7.
1994: Ugo Ramenghi; L Ruggieri; Irma Dianzani; C Rosso; Maria Felice Brizzi; Clara Camaschella; T Pietsch; Giuseppe Saglio
Human peripheral blood granulocytes and myeloid leukemic cell lines express both transcripts encoding for stem cell factor.
Stem cells (Dayton, Ohio) 1994;12(5):521-6.
1994: Giuseppina Barrera; R Muraca; Stefania Pizzimenti; A Serra; C Rosso; Giuseppe Saglio; Maria Giulia Farace; Vito Michele Fazio; Mario U Dianzani
Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line.
Biochemical and biophysical research communications 1994;203(1):553-61.
1994: Angelo Guerrasio; Giuseppe Saglio; C Rosso; Alda Alfarano; Clara Camaschella; Francesco Lo Coco; A Biondi; A Rambaldi; S Nicolis; Sergio Ottolenghi
Expression of GATA-1 mRNA in human myeloid leukemic cells.
Leukemia 1994;8(6):1034-8.
1994: Gianluca Gaidano; Angelo Guerrasio; A Serra; G Rege-Cambrin; Giuseppe Saglio
Molecular mechanisms of tumor progression in chronic myeloproliferative disorders.
Leukemia 1994;8 Suppl 1():S27-9.
1994: G Rege-Cambrin; Gianluca Gaidano; A Serra; P Scaravaglio; T Guglielmelli; Angelo Guerrasio; B Giovinazzo; Giuseppe Saglio
Analysis of the p53 gene in myeloid malignancies associated with chromosomal abnormalities involving the short arm of chromosome 17.
Leukemia 1994;8 Suppl 1():S23-6.
1994: Gianluca Gaidano; A Serra; Angelo Guerrasio; G Rege-Cambrin; U Mazza; Giuseppe Saglio
Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia.
Annals of hematology 1994;68(1):3-7.
1994: Giuseppe Saglio; Angelo Guerrasio; Enrico Gottardi; A Parziale; giovanni martinelli; Alfonso Zaccaria; F Frassoni
Significance of detection of BCR/ABL transcript after allogeneic and autologous transplant.
Bone marrow transplantation 1994;14 Suppl 3():S62-7.
1993: Giuseppe Saglio; M Grazia Borrello; Angelo Guerrasio; G Sozzi; A Serra; P F di Celle; Robin Foa; M Ferrarini; silvio Roncella; C Borgna Pignatti
Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocation.
Genes, chromosomes & cancer 1993;8(1):1-7.
1993: Gianluca Gaidano; Angelo Guerrasio; A Serra; F Carozzi; G R Cambrin; D Petroni; Giuseppe Saglio
Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders.
Leukemia 1993;7(7):946-53.
1993: Clara Camaschella; Giuseppe Saglio
Recent advances in diagnosis of hemoglobinopathies.
Critical reviews in oncology/hematology 1993;14(2):89-105.
1993: Irma Dianzani; Clara Camaschella; Giuseppe Saglio; G B Ferrero; S Ramus; Alberto Ponzone; R G Cotton
Molecular analysis of contiguous exons of the phenylalanine hydroxylase gene: identification of a new PKU mutation.
Journal of medical genetics 1993;30(3):228-31.
1993: P Ballerini; Gianluca Gaidano; J Z Gong; Vittorio Tassi; Giuseppe Saglio; Daniel M Knowles; Riccardo Dalla-Favera
Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.
Blood 1993;81(1):166-76.
1993: A Serra; Angelo Guerrasio; Gianluca Gaidano; C Rosso; G Rege-Cambrin; D Petroni; U Mazza; Giuseppe Saglio
Molecular defects associated with the acute phase CML.
Leukemia & lymphoma 1993;11 Suppl 1():25-8.
1992: G Rege-Cambrin; P Scaravaglio; F Carozzi; silvia giordano; Carola Ponzetto; paolo comoglio; Giuseppe Saglio
Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene.
Cancer genetics and cytogenetics 1992;64(2):170-3.
1992: G Rege-Cambrin; Angelo Guerrasio; P Scaravaglio; C Rosso; F Carozzi; Simonetta Kerim; Giuseppe Saglio
Transient cytogenetic relapse in a Ph1-positive chronic myelogenous leukemia patient previously treated with alpha-interferon.
Leukemia 1992;6(7):738-41.
1992: Angelo Guerrasio; giovanni martinelli; Giuseppe Saglio; C Rosso; Alfonso Zaccaria; G Rosti; N Testoni; Achille Ambrosetti; T Izzi; M Sessarego
Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.
Leukemia 1992;6(6):507-12.
1992: D Petroni; Paola Comi; B Giglioni; A Stacchini; G Martinotti; Angelo Guerrasio; Giuseppe Saglio
Tumorigenic activity of a rearranged c-myc gene from a human T-cell leukemia line.
Carcinogenesis 1992;13(5):883-5.
1992: P Ballerini; Gianluca Gaidano; J Gong; Vittorio Tassi; Giuseppe Saglio; Daniel M Knowles; Riccardo Dalla-Favera
Molecular pathogenesis of HIV-associated lymphomas.
AIDS research and human retroviruses 1992;8(5):731-5.
1992: Enrico Gottardi; Monique Losekoot; Riccardo Fodde; Giuseppe Saglio; Clara Camaschella; L F Bernini
Rapid identification by denaturing gradient gel electrophoresis of mutations in the gamma-globin gene promoters in non-deletion type HPFH.
British journal of haematology 1992;80(4):533-8.
1992: A Serra; Gianluca Gaidano; D Revello; Angelo Guerrasio; P Ballerini; R Dalla Favera; Giuseppe Saglio
A new TaqI polymorphism in the p53 gene.
Nucleic acids research 1992;20(4):928.
1992: Alfonso Zaccaria; giovanni martinelli; M Buzzi; Elisa Zuffa; M D Zamagni; Nicoletta Testoni; Domenico Russo; Angelo Guerrasio; Giuseppe Saglio; Sante Tura
M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia.
Haematologica 1992;77(1):16-20.
1991: G Rege-Cambrin; F Speleman; Simonetta Kerim; P Scaravaglio; F Carozzi; Paola Dal Cin; JL Michaux; F Offner; Giuseppe Saglio; H Van den Berghe
Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders.
Leukemia 1991;5(12):1059-63.
1991: F Gavosto; M Aglietta; F Caligaris Cappio; R Foà; Giuseppe Saglio
Oncology in the nineties: from genes to therapy.
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1991;6(4 Pt 2):451-9.
1991: Simonetta Kerim; G Rege-Cambrin; P Scaravaglio; F Carozzi; Giuseppe Saglio; Massimo Aglietta
Effect of recombinant human IL-3 on the mitotic index and karyotype of hemopoietic cells.
Cancer genetics and cytogenetics 1991;55(2):235-41.
1991: Irma Dianzani; Clara Camaschella; Giuseppe Saglio; S M Forrest; S Ramus; R G Cotton
Simultaneous screening for beta-thalassemia mutations by chemical cleavage of mismatch.
Genomics 1991;11(1):48-53.
1991: Paolo Fortina; Irma Dianzani; A Serra; Enrico Gottardi; Giuseppe Saglio; L Farinasso; Antonio Piga; V Gabutti; Clara Camaschella
A newly-characterized alpha-thalassaemia-1 deletion removes the entire alpha-like globin gene cluster in an Italian family.
British journal of haematology 1991;78(4):529-34.
1991: Paolo Foa; A Iurlo; Giuseppe Saglio; Angelo Guerrasio; Franco Capsoni; Anna Teresa Maiolo
Chronic neutrophilic leukaemia associated with polycythemia vera: pathogenetic implications and therapeutic approach.
British journal of haematology 1991;78(2):286-8.
1991: P F di Celle; Antonino Carbone; Francesco Lo Coco; Angelo Guerrasio; Daniela Diverio; C Rosso; M Lopez; Giuseppe Saglio; R Foà
Identical utilization of T-cell receptor gene regions in B-lymphoid blast crisis of chronic myeloid leukemia and B-precursor acute lymphoblastic leukemia.
Leukemia 1991;5(5):366-72.
1991: C Dati; R Muraca; O Tazartes; Susanna Antoniotti; Isabelle Perroteau; Maurizia Giai; P Cortese; Piero Sismondi; Giuseppe Saglio; Michele De Bortoli
c-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome.
International journal of cancer. Journal international du cancer 1991;47(6):833-8.
1991: Simonetta Kerim; G Rege-Cambrin; P Scaravaglio; L Godio; Giuseppe Saglio; Massimo Aglietta
Trisomy 8 and an unbalanced t(5;17)(q11;p11) characterize two karyotypically independent clones in a case of idiopathic myelofibrosis evolving to acute nonlymphoid leukemia.
Cancer genetics and cytogenetics 1991;52(1):63-9.
1991: Giuseppe Saglio; G Benetton; G R Cambrin; P Scaravaglio; Domenico Novero; Giorgio Palestro
Proto-oncogene and tumor suppressor gene involvement in human lymphomas.
Leukemia 1991;5 Suppl 1():7-11.
1991: Angelo Guerrasio; Alfonso Zaccaria; C Rosso; P Scaravaglio; G Rege Cambrin; V G Bertolli; Giuseppe Saglio; A Tassinari; N Testoni; G Rosti
BCR-ABL transcripts detected by polymerase chain reaction (PCR) after allogenic BMT for CML: analysis of 32 longterm disease free patients.
Bone marrow transplantation 1991;7 Suppl 2():22.
1990: Giuseppe Saglio; Angelo Guerrasio; C Rosso; Alfonso Zaccaria; A Tassinari; A Serra; G Rege-Cambrin; U Mazza; F Gavosto
New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia.
Blood 1990;76(9):1819-24.
1990: Irma Dianzani; M Devoto; Clara Camaschella; Giuseppe Saglio; G B Ferrero; R Cerone; C Romano; Giovanni Romeo; M Giovannini; E Riva
Haplotype distribution and molecular defects at the phenylalanine hydroxylase locus in Italy.
Human genetics 1990;86(1):69-72.
1990: Clara Camaschella; A Serra; Alda Alfarano; Enrico Gottardi; D Revello; Maria Tiziana Bertero; L Oggiano; M Longinotti; Giuseppe Saglio
Deletion and non deletion hereditary persistence of fetal hemoglobin in Italy.
Haematologica 1990;75 Suppl 5():26-30.
1990: Clara Camaschella; Alda Alfarano; Enrico Gottardi; M Travi; P Primignani; Federico Caligaris-Cappio; Giuseppe Saglio
Prenatal diagnosis of fetal hemoglobin Lepore-Boston disease on maternal peripheral blood.
Blood 1990;75(11):2102-6.
1990: Clara Camaschella; Alda Alfarano; Enrico Gottardi; A Serra; D Revello; Giuseppe Saglio
The homozygous state for the -87 C----G beta + thalassaemia.
British journal of haematology 1990;75(1):132-3.
1990: G Rege-Cambrin; Simonetta Kerim; P Scaravaglio; JL Michaux; H Van den Berghe; Giuseppe Saglio
Chromosome abnormalities involving heterochromatic regions in monocytic leukemia.
Cancer genetics and cytogenetics 1990;46(1):99-106.
1990: D F Aghib; J M Bishop; Sergio Ottolenghi; A Guerrasio; A Serra; Giuseppe Saglio
A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability.
Oncogene 1990;5(5):707-11.
1990: Alfonso Zaccaria; Nicoletta Testoni; A Tassinari; B Celso; B S Emanuel; M Budarf; Giuseppe Saglio; Angelo Guerrasio; C Barletta; C Peschle
Molecular and cytogenetic studies of a patient with Philadelphia-negative, BCR-positive chronic myeloid leukemia and t(12;12)(q13;p12).
Genes, chromosomes & cancer 1990;1(4):284-8.
1990: Clara Camaschella; A Serra; Enrico Gottardi; Alda Alfarano; D Revello; U Mazza; Giuseppe Saglio
A new hereditary persistence of fetal hemoglobin deletion has the breakpoint within the 3' beta-globin gene enhancer.
Blood 1990;75(4):1000-5.
1990: Irma Dianzani; Clara Camaschella; Giuseppe Saglio; G B Ferrero; Giovanni Romeo; M Devoto; C Romano; R Cerone; M Giovannini; E Riva
Haplotype distribution and molecular defects of PKU in Italy.
Journal of inherited metabolic disease 1990;13(3):292-4.
1990: Enrico Gottardi; Alda Alfarano; A Serra; G Sciarratta; Maria Tiziana Bertero; Giuseppe Saglio; Clara Camaschella
Molecular diagnosis of A gamma hereditary persistence of fetal hemoglobin using polymerase chain reaction and oligonucleotide analysis.
Haematologica 1990;75(1):17-20.
1989: Giuseppe Saglio; Alfonso Zaccaria; A Tassinari; G Rosti; Francesco Lo Coco; Daniela Diverio; G Rege Cambrin; P Scaravaglio; C Rosso; Angelo Guerrasio
Molecular biology to check patients treated for CML.
Bone marrow transplantation 1989;4 Suppl 4():98-100.
1989: Alfonso Zaccaria; Nicoletta Testoni; A Tassinari; B Celso; Feyruz V Rassool; Giuseppe Saglio; Angelo Guerrasio; Gianantonio Rosti; Sante Tura
Cytogenetic and molecular studies in patients with chronic myeloid leukemia and variant Philadelphia translocations.
Cancer genetics and cytogenetics 1989;42(2):191-201.
1989: Alessandra Stacchini; Carola Ponzetto; Angelo Guerrasio; G Martinotti; G Rege Cambrin; P Scaravaglio; C Rosso; W Piacibello; Massimo Aglietta; Giuseppe Saglio
Expression of the hybrid P210 bcr/abl protein in Philadelphia chromosome positive B-lymphoid cell lines.
Haematologica 1989;74(3):249-54.
1989: Luigi Pegoraro; Fabio Malavasi; Graziella Bellone; Massimo Massaia; Mario Boccadoro; Giuseppe Saglio; Angelo Guerrasio; G Benetton; L Lombardi; R Coda
The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation.
Blood 1989;73(4):1020-7.
1989: Francesco Lo Coco; P Francia di Celle; G Alimena; G De Rossi; R Gastaldi; Giulia Casorati; Giuseppe Saglio; Robin Foa
Acute lymphoblastic leukemia with the 4;11 translocation exhibiting early T cell features.
Leukemia 1989;3(1):79-82.
1989: Francesco Lo Coco; Giuseppe Basso; P F di Celle; A Tassinari; D Pasqualetti; M R De Cuia; Maria Caterina Putti; Giovanni Del Poeta; Carola Ponzetto; Giuseppe Saglio
Molecular characterization of Ph' + hybrid acute leukemia.
Leukemia research 1989;13(12):1061-7.
1989: Angelo Guerrasio; C Rosso; A Tassinari; Alfonso Zaccaria; Giuseppe Saglio
Variant breakpoint positions on chromosome 22 in Ph'-positive chronic myelogenous leukemias.
Haematology and blood transfusion 1989;32():337-8.
1989: Clara Camaschella; A Serra; Enrico Gottardi; Alda Alfarano; D Revello; Maria Tiziana Bertero; Giuseppe Saglio
A new deletion in the beta globin gene cluster associated with high fetal hemoglobin production.
Progress in clinical and biological research 1989;316B():123-32.
1988: Giuseppe Saglio; Angelo Guerrasio; A Tassinari; Carola Ponzetto; Alfonso Zaccaria; P Testoni; B Celso; G Rege Cambrin; A Serra; Luigi Pegoraro
Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies.
Blood 1988;72(4):1203-8.
1988: Gian Carlo Avanzi; P Lista; B Giovinazzo; Roberto Miniero; Giuseppe Saglio; G Benetton; R Coda; G Cattoretti; Luigi Pegoraro
Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features.
British journal of haematology 1988;69(3):359-66.
1988: Alfonso Zaccaria; A Tassinari; Giuseppe Saglio; Angelo Guerrasio; Nicoletta Testoni; B Celso; Gianantonio Rosti; Sante Tura
Cytogenetic and molecular analyses in Philadelphia chromosome positive acute lymphoblastic leukaemia.
British journal of haematology 1988;69(3):424-6.
1988: A Tassinari; Alfonso Zaccaria; Giuseppe Saglio; Angelo Guerrasio; Nicoletta Testoni; B Celso; Gianantonio Rosti; G R Cambrin; Sante Tura
Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia.
Haematologica 1988;73(4):326-7.
1988: Clara Camaschella; A Serra; Giuseppe Saglio; Maria Tiziana Bertero; U Mazza; S Terzoli; Bruno Brambati; Laura Cremonesi; M Travi; M Ferrari
Meiotic recombination in the beta globin gene cluster causing an error in prenatal diagnosis of beta thalassaemia.
Journal of medical genetics 1988;25(5):307-10.
1988: Sergio Ottolenghi; Clara Camaschella; Paola Comi; B Giglioni; M Longinotti; L Oggiano; F Dore; G Sciarratta; G Ivaldi; Giuseppe Saglio
A frequent A gamma-hereditary persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with beta-thalassemia.
Human genetics 1988;79(1):13-7.
1988: M Pirastu; Giuseppe Saglio; Clara Camaschella; A Loi; A Serra; T Bertero; W Gabutti; A Cao
Delineation of specific beta-thalassemia mutations in high-risk areas of Italy: a prerequisite for prenatal diagnosis.
Blood 1988;71(4):983-8.
1988: Graziella Bellone; Gian Carlo Avanzi; P Lista; J Hibbin; Giuseppe Saglio; G Benetton; Robin Foa; Luigi Pegoraro
Soluble factor(s) released by the PF-382 T-cell line enhances the stimulatory effect of monocytes on the BFU-E growth.
Journal of cellular physiology 1988;135(1):127-32.
1988: M Ferrari; Laura Cremonesi; M Travi; M Seia; A Cantù-Rajnoldi; Maurizio Sampietro; Bruno Brambati; W Gabutti; M Campogrande; Giuseppe Saglio
First trimester diagnosis of beta-thalassemia by DNA polymorphism analysis in the Italian population.
Birth defects original article series 1988;23(5B):465-70.
1988: Vincenzo Callea; Fortunato Morabito; P Lista; Luigi Pegoraro; G R Cambrin; Angelo Guerrasio; Giuseppe Saglio; A Tassinari; Maria Teresa Fierro; Pasquale Iacopino
Multilineage cell involvement in Ph1-negative, bcr-negative chronic myeloid leukemia.
Leukemia research 1988;12(8):637-45.
1987: Gian Carlo Avanzi; B Giovinazzo; Giuseppe Saglio; Angelo Guerrasio; Arturo Rosso; Marilena Bertini; Luigi Resegotti; Luigi Pegoraro
Duplication of Ph and of 9q+ chromosomes during the blastic transformation of a CML case.
Cancer genetics and cytogenetics 1987;29(1):57-63.
1987: Fortunato Morabito; A Tassinari; Vincenzo Callea; Maura Brugiatelli; Maria Teresa Fierro; Giuseppe Saglio; A Neri; R Foà
Germ-line configuration of the T-cell receptor beta-chain gene in B-cell chronic lymphoproliferative disorders which co-express T-cell antigens.
European journal of haematology 1987;39(5):412-7.
1987: C Camaschella; Maria Tiziana Bertero; A Serra; M Dall'Acqua; P Gasparini; M Trento; L Vettore; G Perona; Giuseppe Saglio; U Mazza
A benign form of thalassaemia intermedia may be determined by the interaction of triplicated alpha locus and heterozygous beta-thalassaemia.
British journal of haematology 1987;66(1):103-7.
1987: Angelo Guerrasio; Gian Carlo Avanzi; Luigi Pegoraro; X Estivill; A Serra; M C Giubellino; Maria Teresa Fierro; A Novarino; Robin Foa; Giuseppe Saglio
Rearrangement of the c-myc oncogene with heavy-chain immunoglobulin enhancer in tumor DNA from an acute lymphoblastic leukemia patient.
Journal of the National Cancer Institute 1987;78(5):845-51.
1987: Clara Camaschella; Giuseppe Saglio; A Serra; Angelo Guerrasio; T Bertero; G Rege-Cambrin; A Loi; M Pirastu
Molecular characterization of thalassemia intermedia in Italy.
Birth defects original article series 1987;23(5A):111-6.
1987: D Aghib; S Ottolenghi; Angelo Guerrasio; A Serra; C Barletta; R Dalla Favera; M Rocchi; Giuseppe Saglio; F Gavosto
A human leukemic T-cell line bears an abnormal and overexpressed c-myc gene: molecular and functional characterization of the rearrangement.
Haematology and blood transfusion 1987;31():263-4.
1987: D Aghib; Sergio Ottolenghi; Mariano Rocchi; Angelo Guerrasio; Giuseppe Saglio
A novel type of c-myc translocation in a T lymphoma cell line.
Annals of the New York Academy of Sciences 1987;511():338-42.
1987: Giuseppe Saglio; Luigi Pegoraro; Gian Carlo Avanzi; B Giovinazzo; Franco Locatelli; Michele Falda; A Tassinari; Alfonso Zaccaria; V Attadia; G R Cambrin
Significance of the Philadelphia chromosome in acute leukemias: variable correlation with rearrangements involving the c-abl and bcr genes.
Annals of the New York Academy of Sciences 1987;511():270-6.
1986: Giuseppe Saglio; Clara Camaschella; A Serra; T Bertero; G Rege Cambrin; Angelo Guerrasio; U Mazza; Paola Izzo; F Terragni; B Giglioni
Italian type of deletional hereditary persistence of fetal hemoglobin.
Blood 1986;68(3):646-51.
1986: Giuseppe Saglio; B S Emanuel; Angelo Guerrasio; M C Giubellino; A Serra; P Lusso; G R Cambrin; U Mazza; F Malavasi; Luigi Pegoraro
3' c-myc rearrangement in a human leukemic T-cell line.
Cancer research 1986;46(3):1413-7.
1986: Clara Camaschella; Giuseppe Saglio; A Serra; Laura Cremonesi; M Travi; M Ferrari
Fetal diagnosis of beta-thalassaemia by DNA analysis in Italy.
Lancet 1986;1(8477):390.
1985: Sergio Ottolenghi; B Giglioni; C Casini; S Merli; Roberto Mantovani; Paola Comi; A Serra; Angelo Guerrasio; C Camaschella; Giuseppe Saglio
Heterogeneity of molecular defects underlying hereditary persistence of fetal hemoglobin in Mediterranean area.
Progress in clinical and biological research 1985;191():151-61.
1985: Sergio Ottolenghi; B Giglioni; Paola Comi; serena guida; C Casini; S Merli; Roberto Mantovani; F Terragni; D Aghib; Giuseppe Saglio
Heterogeneity of delta, beta-thalassemia and hereditary persistence of Hb F in the Mediterranean area.
Annals of the New York Academy of Sciences 1985;445():170-6.
1984: B Giglioni; C Casini; Roberto Mantovani; S Merli; Paola Comi; Sergio Ottolenghi; Giuseppe Saglio; C Camaschella; U Mazza
A molecular study of a family with Greek hereditary persistence of fetal hemoglobin and beta-thalassemia.
The EMBO journal 1984;3(11):2641-5.
1984: T Bertero; Clara Camaschella; G Rege Cambrin; A Serra; C Giubellino; C Amione; E Gottardi; Giuseppe Saglio
Molecular studies on sickle cell anemia in Sicily: preliminary results.
Haematologica 1984;69(5):513-20.
1983: M Presta; B Giglioni; S Ottolenghi; ALESSANDRO MASSIMO GIANNI; A Capaldi; M Trento; Giuseppe Saglio
Analysis of human embryonic hemoglobins and globins by isoelectric focusing.
Haematologica 1983;68(4):443-53.
1982: Giuseppe Saglio; C Camaschella; Angelo Guerrasio; G R Cambrin; A Capaldi; P G Pich; M Trento; U Mazza
G gamma and a gamma globin chain synthesis in bone marrow and peripheral blood of beta-thalassaemia homozygotes.
British journal of haematology 1982;52(2):225-31.
1981: C Camaschella; Giuseppe Saglio; P G Pich; P Canavoso; R Ferraris; G Bianco; U Mazza
Thoracic extramedullary hematopoiesis in thalassemia intermedia during adult life: a report of 9 cases.
Haematologica 1981;66(5):613-26.
1980: U Mazza; T Meloni; Onorata David; P G Pich; C Camaschella; Giuseppe Saglio; M A Ciocca Vasino; Angelo Guerrasio; Giuseppe Ricco
gamma chain composition in five Italian newborns heterozygous for Hb F Malta G gamma-117 His leads to Arg.
British journal of haematology 1980;44(1):93-9.